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Executive summary 
 
As part of the Victorian Water Trust’s water conservation initiative in 2007, DPI, through the 
Environmental Health and Chemistry platform’s Queenscliff section, was contracted to 
undertake an assessment of hormones in municipal wastewater treatment plant (WWTP) 
discharges across the State of Victoria.   
 
The project was conducted between May 2006 and September 2007, and involved the 
gathering of generic and specific information on all WWTPs in Victoria, and then using that 
information to produce a list of target WWTPs (i.e. those WWTPs whose effluent we wished 
to sample) sorted by location (north and south of the state) and treatment type. In all, some 46 
WWTPs were chosen for further study of their final discharges. These included lagoon-based 
plants and those with activated sludge based processes. Permission was obtained from all the 
relevant water authorities to collect samples of final effluent at point of discharge to the 
environment, whether that is to a creek, a river, the ocean, or the land.  
 
Samples were collected in August 2006, and then again in late February-early March 2007, and 
subjected to a number of biological and chemical analyses, including toxicity tests, 
measurement of hormonal (estrogenic and androgenic) activity using yeast-based bioassays, 
and the measurement of specific hormonal concentrations using enzyme-linked 
immunosorbent assays (ELISA). 
 
No sample produced a response in the androgen assay. Lack of assay response was related to 
lack of androgenic compounds, rather than the direct toxic effect of the effluent. Assessment 
of testosterone and androstenedione concentrations by ELISA suggests that there were indeed 
androgens present in the WWTP samples, but at concentrations below 3 ng/L (testosterone), 
and below 10 ng/L (androstenedione). Although here is very little information on the 
androgenic activity, or androgen concentrations in WWTP effluents, the concentrations of 
testosterone and androstenedione observed were comparable with that recently reported in 
Australia. 
 
Almost all of the effluents examined showed estrogenic activity, to a greater or lesser extent 
(“not detected” to 62 ng/L estradiol equivalents). On the whole, the levels of estrogenic 
activity observed were to the lower end of the range observed overseas in the northern 
hemisphere, and comparable with that recently reported in Australia and New Zealand using 
similar, human-estrogen receptor based assays (“not detected” to ~ 10 ng/L estradiol 
equivalents). The reassuring low/no assay response is bolstered by the chemical assessment of 
estradiol and estrone concentrations by ELISA, which returned concentrations of these 
compounds for the most part below 10 ng/L. 
 
From an aquatic environmental perspective, it is difficult to say with any certainty what the 
potential risk to aquatic organisms in waters receiving these effluents will be. Typically, in 
environmental risk assessment one first looks to agreed national or international guideline or 
trigger values for the type of waters being assessed. In this case, there are as yet no guideline 
values.Without guideline values to drive the assessment, then one compares a chemical’s 
concentration in a sample (in this case a WWTP effluent) with data obtained from 
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toxicological experiments in which the concentration known to elicit a specific effect has been 
determined. In this case, levels of estradiol were typically between the lowest reported level to 
induce the production of female-only proteins in male fish (plasma vitellogen; 1 ng/L), and the  
lowest concentration of known to induce intersex in fish (8 ng/L). Consequently, such levels in 
a WWTP discharge are likely to be an environmental risk if there is little or no dilution of the 
discharge by the receiving water, i.e. discharge represents major component of stream flow. In 
short, to truly assess the risk (hormonal impact) of these WWTP effluents, in vivo testing needs 
to be undertaken, ideally with a representative native species but failing that with a ‘standard’ 
species such as the fathead minnow. 
 
Across Victoria, as indeed elsewhere, a range of different sewage treatment approaches and 
practices occur at a range of different locations with different climatic influences on WWTP 
operation. Without marrying explicit details of treatment processes with effluent hormone 
concentrations, it is difficult to extrapolate results from one location to another. For instance, 
even with activated sludge treatment, there can be wide differences in key parameters such as 
hydraulic residence time, and lagoons are potentially exposed to very different temperature 
regimes affecting performance. The best advice for treatment plant operators is, “have the 
hormonal activity of your plant measured.” 
 
When this program began, the ‘watching brief,’ being held in Australia on the topic of 
endocrine disrupting chemicals and their potential effects on aquatic wildlife was considered 
too passive by many. It still is, by some. Despite the assurance our results may provide (of 
minimal impact in most cases if there is significant dilution), there is still a need for further 
extensive on-ground, reassurance research to provide data for higher-level risk assessment by 
industry and government agencies. 
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Glossary of terms 
 
Abiotic: non-living factors of the environment, including light, temperature, inorganic soil 
particles and rocks, water, and atmospheric gases. 
Activated sludge: generic name for an intensive biological treatment of waste in which 
bacteria are suspended in a tank, and vigorously aerated with a hydraulic retention time 
(HRT) of 5-20+ hours. The objective of this process is to convert both the soluble and insoluble 
from a wastewater stream into a flocculant microbial suspension that is readily settleable, e.g. 
through gravitational solid-liquid separation techniques. Although there are many variations 
on the process, typically, a portion of the settled biological sludge is returned to the head 
aeration tank with additional incoming waste.  
Agrochemical: for the purpose of this report an agrochemical includes any substance or 
organism used to:  
• Destroy, stupefy, repel, inhibit the feeding of, or prevent pests on plants or other things;  
• Destroy a plant or to modify its physiology;  
• Modify the effect of another agricultural chemical product; or  
• Attract a pest for the purpose of destroying it.  
This encompasses all herbicides, insecticides and fungicides. Dairy cleansers for on-farm use, 
crop markers, insect repellents for use on humans, swimming pool disinfectants, algacides, 
rodenticides, antifouling paints, timber preservatives, some pest traps and barriers using 
chemical attractants, and household and home garden products for pest and weed control are 
also encompassed by the above definition. Fertilisers are not considered an agrochemical for 
the purposes of this report unless they modify the physiology of a plant. 
Androgen: the generic term for any natural or synthetic compound, but usually a steroid 
hormone, that stimulates or controls the development and maintenance of masculine 
characteristics in vertebrates by binding to androgen receptors. This includes the activity of 
the accessory male sex organs and development of male secondary sex characteristics. 
Androgens are also the precursor of all estrogens, the female sex hormones. The primary and 
most well-known androgen is testosterone. 
Androstenedione: also known as 4-androstenedione, a steroid hormone produced in the 
adrenal glands and the gonads as an intermediate step in the biochemical pathway that 
produces the androgen testosterone, and the estrogens estrone and estradiol. 
Androsterone: a metabolite of testosterone, or of progesterone, that also exerts minor 
masculinising effects, but with one-seventh the intensity of testosterone. It is found in 
approximately equal amounts in the plasma and urine of both males and females. 
ANZECC: Australia and New Zealand Environment and Conservation Council. 
Aquatic life: the biological life (e.g. algae, fish, frogs etc.) in or on fresh, marine or estuarine 
waters (surface or groundwaters).  
ARMCANZ:  Agriculture and Resource Management Council of Australia and New Zealand. 
BDL: Below Determination Limit. 
Biological filter plants: also known as percolating or trickling (trickle) filter plants, generally 
comprise a tank with a biofilm supported on coarse media upon which the sewage liquor 
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(post-primary sedimentation) is sprayed. The water contact time with the biofilm is often 
quite short, around 30 min. To improve the effluent quality an increasing number of BFP have 
some form of tertiary treatment. 
Contaminant: a chemical that is present in the environment as a consequence of 
anthropogenic activity. A material described as a ‘contaminant’ is one that is either not 
naturally present in the environment being examined, or is present in unnatural 
concentrations. However, in being described as a contaminant, no judgement is being made 
about whether or not the material is having an adverse effect on the environment, or 
organisms therein – the material is simply present in the environment. 
Dihydrotestosterone: 5α-Dihydrotestosterone, or DHT is a biologically active metabolite of 
the steroid hormone testosterone, formed primarily in the prostate gland, testes, hair follicles, 
and adrenal glands by the enzyme 5α-reductase. 
Drinking water: water suitable for human consumption without deleterious health risk. 
Synonymous with ‘potable water,’ but the preferred term since it is better understood by the 
community at large. 
Endocrine disrupting chemicals: Exogenous agents that interfere with the production, release, 
transport, metabolism, binding, action, or elimination of the natural hormones in the body (of 
a human and/or wildlife species) responsible for the maintenance of homeostasis and the 
regulation of developmental processes (Kavlock, 1999). Also defined as: 
• Exogenous substance or mixture that alters function(s) of the endocrine system and 
consequently causes adverse health effects in an intact organism, or in its progeny, or 
(sub)-populations (WHO/IPCS, 2002). 
Environmental hazard: anything with the potential to cause injury, illness and damage to both 
living and non-living things within the environment.  A danger posed to the environment, 
whether imminent or otherwise, resulting from any activities, practices, the location, storage 
or handling of any substance having toxic, corrosive, flammable, explosive, infectious or 
otherwise dangerous characteristics (adopted from the Environment Protection Act 1970 (Vic), 
Section 4). 
Environmental impact: any impact on plants, animals or the environment caused by human 
activities is an environmental impact. Impacts may be reversible or irreversible, minor or 
major, affect a whole ecological community or only a few individuals.  
Environmental impact assessment: environmental impact assessment (EIA), also called 
ecological risk assessment (ERA), is the practice of measuring or estimating the nature and 
likelihood of effects of an action (e.g. the application of pest control products or practices) on 
one or more environmental parameters.  
Estradiol: also oestradiol, or 17β-estradiol, this is the major sex hormone in female 
vertebrates, although it is also produced by males. Estradiol represents the major estrogen in 
humans. Estradiol has not only a critical impact on reproductive and sexual functioning, but 
also affects other organs including bone structure. 
Estriol: also oestriol, is one of the three main estrogens produced by humans, although this 
steroid hormone is only produced in significant amounts during pregnancy (as it is made by 
the placenta). 
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Estrone: also oestrone, is an estrogenic steroid hormone derived from androstenedione 
secreted by the ovary. The least prevalent of the three major steroid estrogens (estradiol being 
most prevalent), estrone is relevant to health and disease due to its conversion to estrone 
sulfate, a long-lived derivative that acts as a pool of estrone which can be converted as needed 
to the more active estradiol. Estrone enters a wastewater treatment system either directly from 
excretion of humans (in the free form or as glucuronide or sulfate conjugates) or from the 
oxidation of 17β-estradiol in the treatment plant itself. 
Guideline: Numerical concentration limit or narrative statement to support and maintain 
designated water use. 
In vivo: (biological) process occurring or made to occur within a living organism or natural 
setting. 
In vitro: (biological) process made to occur in a laboratory vessel or other controlled 
experimental environment rather than within a living organism or natural setting. 
LOR: Limit of Reporting. 
Pesticide: see ‘agrochemical.’ 
Potable water: water suitable for human consumption without deleterious health risks. 
Recycled water: water recycled from the effluent of sewage treatment plants (synonymous 
with reclaimed water). 
Reclaimed water: water which, as a result of treatment of waste, is suitable for a direct 
beneficial use or a controlled use that would not otherwise occur (synonymous with recycled 
water). 
Sediment: Unconsolidated mineral and organic particulate material that has settled to the 
bottom of aquatic environments. 
Teratogenicity:  the potential of a chemical to cause structural malformations or defects in 
offspring; the production of structural malformations or defects in offspring (IUPAC, 1993). 
Testosterone: the principal male sex hormone of vertebrates. A steroid hormone, testosterone 
is derived from cholesterol. The largest amounts of testosterone are produced by the testes in 
males. It is also synthesized in far smaller quantities in females by the thecal cells of the 
ovaries, by the placenta, as well as by the zona reticularis of the adrenal cortex in both sexes, 
In both males and females, testosterone plays key roles in health and well-being, e.g. 
enhanced libido, energy, immune function, and protection against osteoporosis.  
Toxicant: A chemical that can produce adverse health effects. 
Trickle filters: see biological filter plants. 
Water recycling: the preferred term for generic water reclamation and reuse in Australia, 
although also defined as the reclamation of effluent generated by a given user for on-site use 
by the same user (such as in industry).  
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 1 
1. Introduction 
 
The last several decades has seen concerns 
raised that a range of chemicals found in 
municipal wastewater treatment plant 
(WWTP) discharges can cause adverse 
environmental impacts. More recently, the 
occurrence of endocrine disrupting 
chemicals (EDCs) in WWTP discharges 
and their impact on aquatic wildlife has 
generated a significant amount of scientific 
and public interest since the publication of 
the book Our Stolen Future 1. Since then, 
substantial evidence has emerged that 
many chemicals induce hormone-like 
effects in wildlife and humans at the 
concentrations observed in the 
environment (concentrations much lower 
than those used in toxicity tests designed 
to see if the chemicals cause cancer) 2.  
• The effluent from municipal WWTPs is 
considered the source of much of the 
EDC input into aquatic environments. 
• Some of the most commonly studied 
compounds found in WWTP discharges 
that show hormonal activity are the 
natural and synthetic estrogens, such as 
17β-estradiol and 17α-ethynyl-estradiol. 
Compared to Europe, Japan and North 
America, there is still very little 
information on the overall level of 
estrogenic activity, or concentrations of 
specific hormonal compounds WWTP 
discharges, including recycled water in 
Australia. The information that is most 
readily available is variable, ranging from 
reports of very low concentrations in 
Queensland, to values in Victoria in line 
with overseas experience 3.   
• This discrepancy between experiences 
across the country is of both scientific 
and practical interest to water 
managers.  
As part of the Victorian Water Trust’s 
water conservation initiative in 2007, DPI, 
through the Environmental Health and 
Chemistry platform’s Queenscliff section, 
was contracted to undertake an assessment 
of hormones in municipal wastewater 
treatment plant discharges across the State 
of Victoria.    
The specific objectives of the project were: 
• To measure the hormonal activity and 
concentration of several specific natural 
hormones (the estrogens estradiol and 
estrone, and the androgens 
testosterone, and androstenedione) in a 
range of Victorian WWTP discharges in 
the Victorian summer and winter. 
• To assess the risk to aquatic 
environments from the hormonal 
activity found in the project surveys. 
• To compare the hormonal activity and 
specific estrogen / androgen 
concentrations with those found 
elsewhere nationally and 
internationally. 
 
 
1.1 References 
1. Colborn T, Dumanoski D, Myers JP 
(1996). Our Stolen Future. Dutton Press, 
New York. 
2. WHO/IPCS (2002). Global assessment 
of the state-of-the-science of endocrine 
disruptors. Edited by: Damstra T, 
Barlow S, Bergman A, Kavlock R, Van 
Der Kraak G. World Health 
Organisation / International Program 
on Chemical Safety. Available on-line: 
http://www.who.int/ipcs/ 
publications/new_issues/endocrine_ 
disruptors/en/index.html 
3. CRC Water Quality & Treatment 
(2007). Occasional Paper 8: Chemicals 
of concern in wastewater treatment 
plant effluent: State of the science in 
Australia. CRC for Water Quality and 
Treatment, Salisbury, Australia.  
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2. Background 
The occurrence of endocrine disrupting 
chemicals (EDCs) in the aquatic 
environment and their impact on 
indigenous fauna has generated a 
significant amount of scientific and public 
interest since the publication of the book 
Our Stolen Future1. Since then, substantial 
evidence has emerged that many chemicals 
induce hormone-like effects in wildlife and 
humans2, at the concentrations observed in 
the environment, i.e. at concentrations 
much lower than those used in toxicity 
tests designed to see if the chemicals cause 
cancer. Chemicals with hormonal activity, 
i.e. potential endocrine disrupters, include: 
• Natural hormones. These can be from 
any animal, and once released into the 
environment, chemicals produced by 
one species can exert hormonal actions 
on other animals, e.g. human hormones 
unintentionally reactivated during the 
processing of human waste in sewage 
effluent, may result in changes to fish.  
• Natural chemicals, including toxins 
produced by components of plants 
(phytoestrogens, such as genistein or 
coumestrol) and certain fungi.  
• Synthetically produced pharmaceuticals 
that are intended to be highly 
hormonally active, e.g. components of 
the contraceptive pill and treatments for 
hormone-responsive cancers. 
• Man-made chemicals and by-products 
released into the environment.  
Estrogen mimics are not the only class of 
endocrine disruptors. Some chemicals 
antagonise male hormones, i.e. they are 
androgenic. Indeed, perversely, some 
compounds may be both estrogen agonists 
and androgen antagonists, e.g. DDE 3.  
The endocrine and reproductive effects of 
EDCs are thought to be due to their ability 
to (1) mimic, (2) antagonise, or (3) disrupt 
the synthesis and metabolism of hormones, 
or (4) disrupt the synthesis and metabolism 
of hormone receptors. The discovery of this 
hormone-like activity occurred long after 
the release of chemicals into the 
environment3, yet for most associations 
between exposure to EDCs and subsequent 
biological outcomes, the mechanism(s) of 
action are still poorly understood 2. This 
can make it difficult to distinguish between 
both direct and indirect effects of exposure 
to EDCs, and primary versus secondary 
effects.  
• Some studies assume that EDCs only 
produce effects on development rate, 
growth and reproduction by disrupting 
hormones controlling reproduction and 
maturation, but life-history traits may 
be the result of toxic effects, or sex-
related differences in sensitivity (i.e. 
survival, condition).  
• To truly assess the endocrine disrupting 
effects of chemicals in fish, for instance, 
one would need to ensure that energy 
intakes have not been affected, i.e. one 
would need to discriminate between 
sublethal effects resulting from changed 
energy intake, and resulting in changed 
condition, from those related to 
endocrine disruption per se.  
The risk to wildlife of exposure to 
environmental estrogens has been 
demonstrated in both field and laboratory2, 
4. Reports of adverse effects (from subtle 
changes in physiology to permanently 
altered sexual differentiation) have come 
from Europe and North America, although 
in many cases the causal link between 
endocrine disruption and effect is unclear. 
There are, however, a number of 
remarkable and well-publicised examples: 
• Male alligators reared in Florida’s Lake 
Apopka have very small penises, an 
effect linked to chemical residues in 
their tissues caused by an accident at a 
chemical plant on the lake’s shores5. 
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• Birds of prey exposed to DDT laid eggs 
with unnaturally thin eggshells, 
resulting in breakage during laying or 
incubation, reduced chick survival and 
ultimately population decline 6. 
• Embryonic abnormalities have been 
observed in fish-eating birds, e.g. in the 
Laurentian Great Lakes, which can be 
ascribed to PCB exposure 7.  
• Exposure of marine gastropods to TBT 
from marine anti-fouling paints causes a 
masculinsation of female gastropods, 
and ultimately population decline 8.  
• The observation of feminised male fish 
near sewage outlets in several UK and 
German rivers 9, 10.  
The effluent from municipal wastewater 
treatment plants (WWTPs) is considered 
the source of much of the EDC input into 
aquatic environments 11,12. Four main 
classes of EDC have been identified in 
sewage effluent: 
• Natural steroid estrogens (eg. 17β-
estradiol, a female sex hormone found 
in all vertebrates). 
• Synthetic estrogens (e.g. 17α-ethinyl 
estradiol, a major constituent of 
common oral contraceptives). 
• Phytoestrogens (e.g. β-sitosterol, 
genistein). 
• Alkylphenols (e.g. 4-nonylphenol and 
bis-phenol-A). 
Some of the most commonly studied 
compounds found in WWTP effluents that 
show hormonal activity are the natural and 
synthetic estrogens, such as 17β-estradiol 
and 17α-ethynylestradiol.  
• 17β-estradiol (E2), estrone (E1), and 
estriol (E3) (Fig. 2.1) are excreted by 
both women and men, mainly as 
conjugates of sulphuric and glucuronic 
acids.  
• Males excrete an estimated 1.6, 3.9 and 
1.5 µg/day of E2, E1 and E3, respectively 
13.  
• The picture is more complex in women. 
Menstruating females excrete an 
estimated 3.5, 8.0 and 4.8 µg/day of E2, 
E1, and E3, respectively, but pregnant 
females excrete two orders of 
magnitude more hormone (an estimated 
259, 600 and 6000 µg/day of E2, E1, and 
E3, respectively) 13.  
 
Based on excretion studies, it is not 
unreasonable to expect that the estrogens 
would be expected in WWTP influents, 
and to perhaps be found in WWTP 
discharges. Indeed, estrogenic steroid 
hormones have been found in WWTP 
discharges in Europe, the USA, Canada 
and Japan, and at concentrations as high as 
64 ng/L E2, 82 ng/L E1, and 18 ng/L E3 14. 
However, in Australia there has until 
recently been very little published 
information on overall hormonal activity 
(estrogenic or androgenic), or the 
concentrations of specific hormones in 
Australian WWTP discharges, or aquatic 
environments, as most effluent monitoring 
is concerned with nutrients, metals and 
organic compounds of industrial origin. 
A suite of steroid hormones is likely 
present in WWTP effluent because the 
chemical properties that affect removal in 
WWTPs (e.g. hydrophobicity) and mass 
loading from human excretion are similar 
for most of the estrogens, androgens and 
progestins.  
• Although little is known of the fate of  
androgens in WWTP processes, nor 
concentrations in WWTP discharges, 
Kirk et al.  15 suggest that most of the 
androgenic activity in municipal 
wastewater with a predominantly 
domestic input is from androgens 
excreted by humans. 
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Figure 2.1 Chemical structures of major 
female sex hormones (estradiol, estrone  
and estriol). 
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Figure 2.3 Chemical structure of 
androstenedione, an androgenic steroid 
hormone and precursor of both 
testosterone and estradiol. 
 
• Chapman et al. 11 suggest that androgen 
levels in human plasma are several 
hundredfold higher than estrogen levels 
in adult males (3000-10000 ng/L 
testosterone cf. 10-60 ng/L estradiol). 
Testosterone concentrations in adult 
females are of the same order of 
magnitude in adult females (200-750 
ng/L testosterone cf. 30-400 ng/L 
estradiol (Tietz (1987), as cited in 11). 
The shortage of information in Australia 
on estrogens in Australian WWTP effluents 
was partly addressed by the publication in 
2005 of the results of our reconnaissance 
survey of the estrogenic activity of seven 
Victorian WWTP discharges undertaken in 
200316.  
• Estrogenic activity was found in all 
samples (<0.5 – 55 ng/L estradiol 
equivalents (EEQ))  
In a second survey in early 2004, we again 
assessed the estrogenic activity of treated 
municipal wastewater, this time from 
twelve WWTPs located in southern 
Victoria and south-eastern South Australia, 
including all seven original WWTPs 17.  
• The levels of estrogenic activity seen 
(<0.5 – 45 ng/L estradiol equivalents 
(EEQ)) were comparable to those 
reported in our 2003 survey, i.e. where 
low concentrations were observed in 
2003, low levels were observed in 2004. 
Similarly where high concentrations 
were observed in 2003, high levels were 
observed in 2004. 
In 2003 and 2004, the discharge with the 
highest estrogenic activity was not from 
the largest population. Indeed, it is one of 
the smallest. This is consistent with 
overseas observations. Differences in 
treatment plant catchment characteristics, 
including population served, commerce-
industry-domestic sewerage mix, 
treatment technology used and other socio-
economic factors may influence the 
influent, and effluent concentration of 
endocrine disrupting chemicals 12. Climatic 
differences can complicate comparisons, or 
use of data from one region to another. For 
instance, temperature is thought to affect 
the rate of degradation of hormones in 
activated sludge plants 11. That said: 
• In both our 2003 and 2004 surveys, the 
estrogenic activity observed was 
comparable with, but generally to the 
lower end of, the range observed 
overseas e.g. in Japan (5-15 ng/L EEQ) 18, 
the USA (21-147 ng/L EEQ) 19,  Sweden 
(<0.1-15 EEQ) 20, and Switzerland (<1-90 
ng/L EEQ) 21, respectively.  
• In both our 2003 and 2004 surveys, the 
estrogenic activity observed was higher 
than that observed in samples obtained 
in 2003 from 15 municipal sewage 
treatment plants in Queensland and 
New Zealand 22.  Of these fifteen plants, 
thirteen effluents were reported as 
having activity <1 ng/L EEQ, with one 
suspended growth/activated sludge 
plant having an activity of 4.2 ng/L 
EEQ, and one trickle filter plant effluent 
having an activity of 6.4 ng/L EEQ 22,11. 
H
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Endocrinology 101: The Endocrine System  
 
 
 
 
The human endocrine system (from Endo 
101, 2006) 
The endocrine system is one of the body’s 
main systems for communicating, 
controlling and coordinating the body’s 
work. In other words, the endocrine system 
is a network of glands, hormones and 
receptors that provides the communication 
and control links between the nervous 
system, and bodily functions such as 
reproduction, immunity, metabolism and 
behaviour. The endocrine system has three 
main components:  
• Endocrine glands: situated at various 
sites around the body, and in specialised 
areas of the brain. The cells in these 
glands secrete specific chemicals called 
hormones. 
• Hormones: chemicals that circulate 
around the body via the blood stream 
and modulate cellular or organ functions 
by binding with receptors in the target 
cells. Hormones that stimulate and 
control the activity of other endocrine 
glands are called trophic hormones. 
• Receptors: in the target cells that, once 
activated by binding of the hormone, 
regulate the functions and processes in 
the tissue through interactions with the 
cell's DNA or other complex 
intracellular signalling processes. 
Although the precise structures and roles 
of the various organs and hormones differ 
between different vertebrates, particularly 
in relation to the different life cycle and 
development stages in different species, 
the endocrine systems of all vertebrates 
are similar to that of humans. Hence, the 
concern that harmful effects seen in 
wildlife following exposure to endocrine 
disrupting chemicals (EDCs) may 
eventually be seen in humans (and vice 
versa).  
• Invertebrates, such as molluscs, 
crustaceans and insects, also have 
endocrine systems that control a similar 
range of body functions, although these 
have evolved along markedly different 
lines to those of vertebrates. 
The endocrine system plays an essential 
and all-pervasive role in the regulation of 
metabolic processes. In other words, this is 
a system that works with the nervous 
system, reproductive system, kidneys, gut, 
liver and fat to help maintain and control 
body energy levels, and the processes of 
reproduction, growth and development, 
homeostasis, and responses to 
surroundings, stress, and injury.  
• To function normally, the body needs 
glands that work correctly, a blood 
supply that works well to move 
hormones through the body to their 
target points, receptor places on the 
target cells for the hormones to do their 
work, and a system for controlling how 
hormones are produced and used. 
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The fundamental role of all endocrine 
systems is to enable the coordinated 
response of one tissue to signals originating 
in either another organ or, in some cases, 
cues originating outside the body.  
• For most endocrine systems, the primary 
objective is to maintain homeostasis, 
avoiding wild swings in hormone levels 
or responses (e.g. the maintenance of 
blood glucose levels by insulin).  
To a large extent all endocrine systems 
operate on a ‘seesaw’ principle, in which 
target cells send feedback signals to the 
regulating cells. If the feedback is negative, 
secretion of the hormone is altered (usually 
reduced).  
• There are usually refinements to this 
simple scenario that enable all the body’s 
endocrine systems to be integrated such 
that organism age, reproductive status, 
nutritional status, and stress levels are 
able to override other endocrine systems 
when danger threatens.  
• This is vital for maintenance of good 
health.   
The homeostatic balance must be set (or 
programmed) before the endocrine system 
will work correctly. For many of the 
endocrine systems, it appears that the 
programming is established during foetal or 
neonatal development, and that an 
abnormal environment at this stage can 
result in permanent misprogramming.  
• In mammals, programming of the 
hypothalamus of the female, but not of 
the male, to respond to gradually rising 
estrogen levels by triggering a positive 
response, is established perinatally, and 
exposure of the female at this time to 
moderate levels of male sex steroids will 
prevent this programming and render 
the female permanently infertile. 
Before sex differentiation, the mammalian 
embryo has the potential to develop into a 
male or female phenotype. Following 
gonadal sex differentiation, perinatal 
testosterone secretion by the testis is 
responsible for masculinisation of the 
body in general. Females avoid 
developing as a male by not switching on 
secretion of testosterone in the ovary. The 
central role of testosterone in 
masculinsation has two important 
implications: 
1. If a genotypic male fails to secrete 
sufficient testosterone, it will not 
masculinise and may develop as a 
phenotypic female (but with testes). 
2. If a genotypic female is exposed to 
sufficient testosterone (or other 
androgen), it will masculinise and may 
develop as a phenotypic male (but with 
ovaries). 
These are not always all or nothing 
scenarios. Partial masculinisation, or 
partial failure of masculinisation, can also 
occur.  
Perhaps the most important aspects of 
these, and other imprinting/programming 
changes is their irreversibility, leading to 
perhaps the greatest concern about 
environmental endocrine disruptors, 
namely that exposure to an agent during 
perinatal life can result in permanent 
adverse or abnormal change. The 
exposure does not need to be chronic, 
simply sufficient at a critical time during 
development. 
Non-mammalian vertebrates differ from 
mammals, and each other, in terms of 
their reproductive strategies. These 
include: 
• Sequential/simultaneous hermaphro-
ditism.  
• Parthenogenesis.  
• Viviparity and ovoviviparity. 
• Gonochromism.  
Breeding frequency may also be more 
limited, and includes the semelparous 
(breed only once) as well as iteroparous 
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(breed two or more times). However, the 
endocrine axes non-mammalian vertebrates 
are similar to that of mammals in their 
operation, in the pattern of feedback 
mechanisms and in the hormones involved. 
For instance: 
• In many male teleosts (bony fishes) 11-
ketoteststerone is the predominant 
circulating androgen (cf. testosterone in 
mammals).  
• Female teleosts produce testosterone, 
and at times circulating levels may be as 
high as that of estradiol. 
• Telesosts also produce a range of 
progesterone-like molecules that cause 
final oocyte maturation and ovulation 
(although in some teleosts the 
corticosteroid deoxycorticosterone has 
the same function).  
• Female amphibians also have high levels 
of circulating androgens as well as 
estrogens during the reproductive 
portions of their lives.  
• Teleosts have a third estrogen receptor 
(ER-γ cf. the two found in mammals (ER-
α and ER-β). 
Complete or partial sex reversal has been 
observed when the eggs, larvae or juveniles 
of non-mammalian vertebrates are exposed 
to androgens or estrogens. Androgens 
usually inhibit female duct (Mullerian) 
development while enhancing male duct 
(Wolffian) development, while estrogens 
typically do the reverse. Estrogens stimulate 
the synthesis of ovalbumin protein in birds, 
and the synthesis of vitellogenins in adult 
female vertebrates that produce yolky eggs, 
i.e. reptiles, birds, amphibians and fish. If 
adult males or immature females are 
exposed to estrogens, they can be induced 
to produce vitellogenins.  
• Plasma vitellogenin can be used as a 
biomarker for exposure to estrogens. 
Endocrine axes do not function in isolation 
from each other, but interact, providing 
organisms with the ability to react and 
adapt to changing circumstance. The 
cross-talk between endocrine systems is 
very complex, and new pathways of 
communication and overlap between the 
various endocrine systems are being 
discovered every year. For instance: 
• The interaction between leptin and the 
reproductive system. In general, 
animals only reproduce only when 
females have sufficient energy reserves 
and food supply is good. When food 
supply and maternal energy (fat) 
reserves are low, elevated leptin 
suppresses reproduction.  
• Pathways such as this play important 
roles in the timing of puberty, in 
regulating seasonal reproduction, and 
even in disorders such as anorexia. 
Cross-talk between the endocrine systems 
can have different consequences at 
different stages of life, and in particular 
during the phase when an endocrine axis 
is being programmed, i.e. when thresholds 
for stimulation and feedback loops are 
being created. 
 
Adapted from:  
1. WHO/IPCS (2002). Global assessment 
of the state-of-the-science of endocrine 
disruptors. Edited by: Damstra T, 
Barlow S, Bergman A, Kavlock R, Van 
Der Kraak G. World Health 
Organisation / International Program 
on Chemical Safety. Available on-line: 
www.who.int/ipcs/publications/new 
issues/endocrine_ disruptors/ 
en/index.html 
2. Endo 101 (2006). Endo 101: the 
endocrine system. The Hormone 
Foundation. Available on-line: 
www.hormone.org/endo101/  
3. Stryer L (1995). Biochemistry. 4th Ed. 
W.H. freeman & Co., New York. 
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3. Material and Methods 
The project was overseen and guided by a 
Project Steering Committee comprised of 
representatives of: 
• Department of Sustainability and 
Environment (for the Victorian Water 
trust) 
• Department of Primary Industries 
• Melbourne Water 
• Wannon Water 
• South-East Water 
• Environment Protection Authority 
Victoria 
• Corangamite Catchment Management 
Authority 
The project was managed by DPI, and 
delivered by Environmental Health & 
Chemistry’s Queenscliff Section, in 
collaboration with Dr. Fujio Shiraishi of the 
National Institute for Environmental 
Studies, Japan, and Dr. Scott Salzman of 
Deakin University. 
In its early stages, the project was faced 
with a choice, whether to conduct in-depth 
investigations on a limited number of 
WWTPs (i.e. from raw influent to treated 
effluent), or to take a broader look at a 
number of WWTPS (i.e. measure hormonal 
activity at a large number of locations).  
• After much discussion, the Project 
Steering Committee decided to take the 
latter approach, in part justifying the 
decision on the paucity of information on 
hormonal activity of Victorian WWTP 
discharges. 
The Project Steering Committee also 
suggested that the project should 
investigate treatment type and temperature 
because they are considered two of the 
major variables influencing 
persistence/degradation of hormones in the 
treatment process.  
• Although most of Victoria’s population, 
and hence most of the biggest WWTPs, 
are south of the Dividing Range, 
available information suggested there 
were sufficient numbers of WWTPs 
north of the Dividing Range to allow 
plants to be grouped by general 
location (as surrogate for temperature), 
as well as treatment types. 
Basic information on WWTPs (e.g. 
treatment type), was obtained from 
published information on water business 
websites and in reports, and/or directly 
from the water authorities. Using this 
information, we ascertained that, although 
there are some 185 WWTPs in the state, 
there were: 
(a) An insufficient number of activated 
sludge plants with BNR in the state to 
allow us to sub-divide the activated 
sludge category as we had hoped;  
(b) There were only nine WWTPs using 
activated sludge systems of any 
description in our ‘north’;  
(c) There were plants using activated 
sludge processes with extended 
aeration (IDEA process) that formed a 
category of their own. 
Consequently, a primary list of targets 
was compiled, that included:  
• Activated sludge-based plants (AS; S 
(south)=13, N(north)=5) 
• Activated sludge (extended aeration)-
based plants (AS(EA); S=7, N=4). 
• Lagoon based plants (L; S=8, N=8). 
• Other – measured because of their 
importance to a particular water 
authority, but not included in the 
statistical comparsions because of the 
use of a different process to the other 
plants in our survey (1).  
Chemical and biochemical analyses 
included: 
• Toxicity. 
• Hormonal activity (e.g. estrogenic, 
androgenic activity). 
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• Specific hormone concetrations 
(estradiol, estrone, testosterone, 
androstenedione). 
• pH, electrical conductivity, TOC (total 
organic carbon), chlorophyll ‘a’ (Summer 
2007, only). 
 
3.1 Sample Collection 
Two surveys were conducted of an 
intended 46 WWTPs: 
• Phase 1 (Winter 2006) in the three weeks 
between August 14 and 31, 2006. 
• Phase 2 (Summer 2007) in the four weeks 
from February 12 – March 7, 2007. 
• Samples could not be obtained from one 
WWTP in the Winter 2006 survey for 
logistical reasons, and was removed 
from the Summer 2007 survey. 
• Samples could not be obtained from five 
WWTPs in the Summer 2007 survey, also 
for logistical reasons. The Winter 2006 
data has been retained in statistical 
comparisons.  
Water samples were collected as ‘grab,’ or 
spot samples, from each facility at the point 
at which effluent enters the environment, 
either as recycled water or direct discharge 
to the receiving water.  
• In Winter 2006, 1.5-2.5L of water was 
collected.  
• In Summer 2007, 5-6L of water was 
collected (to facilitate additional method 
development and testing not reported 
herein).  
Although for the most part discharges were 
sampled in the same manner, at times 
sampling protocols were modified 
dependent upon on-site conditions. For 
instance, generally samples were collected 
by members of the research team, although 
some samples were collected by plant 
personnel (for safety reasons or 
convenience). Samples were directly 
collected in glass bottles, stored on ice, and 
then at 4°C until processed. 
3.2 Sample preparation: bioassay 
For each WWTP site, a sample (1L) was 
extracted for the measurement of 
hormonal activity (estrogenic, androgenic 
and retinoic) activity and toxicity, using 
the yeast two-hybrid assay and 
photobacterium toxicity assay.   
Prior to filtration or extraction, 10mL of an 
acetic acid: water: methanol (1:9:90) buffer 
solution was added to the sample (1 L) to 
ensure an acid pH. Samples were then 
filtered with GF/C filters (Whatman 
International Ltd, UK) to remove 
particulate matter. The sample was then 
passed through a C18 SPE disk (octadecyl 
C18; Empore; 47 mm; 3M, MN, USA), 
which had previously been conditioned 
with sequential washes of methanol (10 
mL), and deionised water (water having a 
resistivity of at least 18 MΩ cm-1 
produced by passing singly distilled 
water through a Milli-Q Water 
Purification System; 20 mL). Thereafter, 
the disks were immediately washed with 
deionised water (20 mL), and dried at 
35°C on a hotplate for approximately 1.5 
hours. Each disk was wrapped separately 
in aluminium foil, labelled, placed inside 
another labelled plastic bag, and stored at 
-4°C until transported to Japan for analyte 
elution and analysis.  
Each disk was eluted with methanol (10 
mL) into a screw cap glass tube (Iwaki 
borosilicate glass; Asahi Techno Glass, 
Tokyo), and the resulting solution 
evaporated to dryness with nitrogen, and 
the residue immediately frozen (-20° C) 
until separation the following day. The 
sample was then subjected to a crude 
fractionation process to isolate fractions 
containing non-polar chemicals (e.g. many 
of the persistent organic pollutants), the 
steroid hormones, and polar compounds.  
The sample was re-suspended in a 
mixture of 3:1 hexane: dichloromethane (1 
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mL), and loaded onto a florisil column 
(Varian Bond Elut-FL, 500 mg, 3mL; CA, 
USA) which had previously been 
conditioned with hexane (2.5 mL). After 
loading of the sample onto the column, the 
column was washed twice with a mixture 
of 3:1 hexane: dichloromethane (2.5 mL). 
The sample solution passing through the 
florisil column and the collected washes 
were combined and designated the W 
fraction. Thereafter, the cartridge was 
washed with a mixture of 1:9 acetone: 
dichloromethane (2 x 2.5 mL). The collected 
washes were combined and designated the 
FL fraction. Finally, the cartridge was 
washed with methanol (2 x 2.5 mL), and the 
collected wash designated the RM fraction. 
The W, FL and RM fractions were 
evaporated to dryness under nitrogen, and 
frozen (-20°C) until subjected to a number 
of analyses: 
• Modified photobacterium toxicity test. 
• Yeast human androgen receptor (hAR) 
bioassay. 
• Yeast human estrogen receptor (hER) 
bioassay. 
• Yeast medaka estrogen receptor (mER) 
bioassay. 
• Yeast retinoic acid receptor (RAR) 
bioassay (data not reported). 
• Yeast aryl hydrocarbon receptor (AhR) 
bioassay (data not reported). 
 
3.3 Measurement of hormonal activity 
with yeast two-hybrid assay 
incorporating estrogen / androgen 
receptors 
Samples and standards were removed from 
the freezer 1h prior to analysis, thawed, and 
dissolved in DMSO (100µL), effectively 
resulting in 10,000-fold concentration from 
the original effluent sample.  
The agonist activities of the treated 
municipal effluent samples were measured 
with a yeast two-hybrid estrogenicity assay 
system using yeast cells (Saccharomyces 
cerevisiae Y190) into which the human 
estrogen receptor ERα or the estrogen 
receptor from Japanese medaka (Oryzias 
latipes) had been inserted. Both were 
adapted to a chemiluminescent reported 
gene (for β-galactosidase) method 
employing a 96–well culture plate 1.  
In short, yeast cells were cultured (30°C, 
overnight; Sanyo Incubator, Tokyo, Japan) 
in a modified SD (Sabouraud Dextrose) 
medium (lacking tryptophan and leucine). 
The yeast solution cell density was 
measured (595 nm), and, if necessary, 
adjusted to 1.75 -1.85 readings for constant 
cell density by diluting with modified SD 
medium. Modified SD solution (60 µL) 
was added to each well of the first row of 
a 96-well culture plate (Sumilon 96F 
disposable plates; Sumilon Bakelite Co., 
Tokyo, Japan). Thereafter, 2% DMSO / 
modified SD solution (60 µL) was 
automatically added (Nichiryo NSP-7000 
Multi-channel Auto Sampling System, 
Nichiryo Co., Tokyo, Japan) to each well 
of the 2nd - 8th rows of the plate. Six 
samples were run on each plate, with 
aliquots of each sample (60 µL), added to 
two, neighbouring wells of the 1st row of 
the plate. An aliquot was removed from 
each well of row 1, and added to row 2 to 
dilute 2-fold. This process was then 
repeated from rows 2–7. No sample 
solution from row 7 was added to the 8th 
row. Thereafter, yeast solution (60 µL) 
was added to all wells, the plate shaken 
(30s; Taiyo S-2000 Automatic Mixer, 
Taiyo, Tokyo, Japan) and then incubated 
(30°C, 4 h).   
After incubation, a mixed solution (80 µL) 
for inducing chemiluminescence and for 
enzymatic digestion (30 µL of Aurora 
GAL-XE Reaction Buffer containing 
GalactaLux substrate, MP Biomedicals 
Inc., CA, USA and 50 µL of Zymolyase 
20T diluted with Z buffer (a mixture of 
21.5 g Na2HPO4.12H20; 6.2 g Na2HPO4. 
 14
.2H20; 0.75g KCl; 0.246 g MgSO4.7H20 in 1L 
deionised water)) was then added to each 
well, and the plate incubated (37°C, 1 h; 
Ikemoto Scientific Technology Co, Tokyo, 
Japan). Thereafter, a light emission 
accelerator solution (50 µL; Aurora 
Accelerator, MP Biomedicals Inc., CA, 
USA) was added to each well, and the 
chemiluminescence produced by released 
β-galactosidase measured with a 96-well 
plate luminometer (Luminescencer-JNR 
AB-2100, ATTO Bioinstruments, Tokyo, 
Japan). Agonist activity was recorded as the 
EC x 10 (defined as the concentration of test 
solution producing a chemiluminescent 
signal 10 times that of the blank (negative) 
control). Two positive controls were used, 
namely 17β-estradiol and estrone (Wako 
Pure Chemical Industries Ltd, Osaka, 
Japan) in both the mER and hER assays, 
and dihydrotesosterone and 11-keto- 
testosterone (Wako Pure Chemical 
Industries Ltd, Osaka, Japan) in the hAR 
assay. A solvent (vehicle) control (DMSO, 
Nakalai Tesque Co., Kyoto, Japan) was also 
used. 
 
3.4 Measurement of toxicity using a 
modified photobacterium toxicity test  
The Microtox acute toxicity, screening test 
(developed by Beckman Instruments, Inc.) 
was adapted for use with a 96-well 
microplate, and from here-on is referred to 
as the photobacterium toxicity test (P.B.). 
This bioassay is based on the production of 
light per unit time by living luminescent 
bacteria, which is a reflection of the rate at 
which a complex set of energy-producing 
reactions is operating. Chemical inhibition 
of any of the enzymes will alter this rate, 
consequently changing the amount of light 
produced. Chemical inhibition is 
determined by measuring the IC50 (the 
chemical concentration calculated to inhibit 
luminescence in 50% of the test organisms). 
In this study, the IC50 values are reported 
according to a concentration ratio (C.R.), 
which is effectively how much the sample 
would have had to have been diluted to 
inhibit luminescence in 50% of the 
photobacteria. In short, the lower the IC50 
(C.R.) reported, the higher the toxicity of 
the sample (and vice versa, i.e. the higher 
the IC50 (C.R.), the lower the toxicity).  
Photobacterium cells were cultured at 
room temperature overnight in an equal 
mixture of Marine Broth medium and T 
medium (peptone, 0.4 g; glycerol 3.5 g; 
NaCl 20 g; MgSO4∙7H2O, 29 g; KCl, 0.9 g; 
K2HPO4, 0.1 g; 1M MOPS buffer solution, 
4.5 mL). The bacteria solution was well 
mixed, and its luminescence intensity 
measured for adjustment by placing an 
aliquot of the mixture (200 μL) into a 
black 96 microplate and reading the 
intensity (Luminescencer-JNR AB-2100, 
ATTO Bioinstruments, Tokyo, Japan). The 
bacterial mixture is deemed acceptable if 
the measured intensity is greater than 
200,000.  
After adding equal amounts of 10% 
glycerol T medium to the bacterial 
solution, the resulting mixture was 
diluted 10 times by adding T medium (60 
µL) to each well of the first row of a 96-
well culture plate (Sumilon 96F disposable 
plates; Sumilon Bakelite Co., Tokyo, 
Japan). Thereafter, 2% DMSO / T med. 
solution (60 µL) was automatically added 
(Nichiryo NSP-7000 Multi-channel Auto 
Sampling System, Nichiryo Co., Tokyo, 
Japan) to each well of the 2nd - 8th rows 
of the plate.  
Test samples (from extraction process 
described earlier (3.2)) are resuspended in 
DMSO (100 µL). An aliquot of the 
resuspension (20 µL) is then mixed with T 
medium (480 µL), effectively diluting the 
sample 25-fold, and providng a 4% DMSO 
solution for testing. 
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• Diluting the sample at this point 
effectively reduces sample pre-
concentration (i.e. from grab sample to 
testing) to 400-fold. 
Five samples plus a control (4% DMSO), 
were run on each plate. In short, aliquots of 
each sample (or control; 60 µL) were added 
to two, neighbouring wells of the 1st row of 
the plate. An aliquot was removed from 
each well of row 1, and added to row 2 to 
dilute 2-fold. This process was then 
repeated from rows 2–7. No sample 
solution from row 7 was added to the 8th 
row. Thereafter, photobacterium solution 
(60 µL) was added to all wells, the plate 
shaken (30s; Taiyo S-2000 Automatic Mixer, 
Taiyo, Tokyo, Japan) and after five minutes 
the chemiluminescence measured with a 
96-well plate luminometer (Luminescencer-
JNR AB-2100, ATTO Bioinstruments, 
Tokyo, Japan). 
 
 
3.5 Measurement of hormone 
concentrations using ELISA  
 
3.5.1 Sample preparation and extraction 
For each WWTP site, a sample (500 mL) 
was extracted for the measurement of the 
concentration of four, specific hormones 
(estradiol, estrone, testosterone, andro-
stenedione) using commercial enzyme-
linked immunosorbent assay (ELISA) kits.  
Prior to filtration, 5mL of an acetic acid: 
water: methanol (1:9:90) buffer solution was 
added to the sample to ensure an acid pH. 
Samples were then filtered with GF/C filters 
(Whatman International Ltd, UK) to 
remove particulate matter. The sample was 
then passed through a C18 SPE column 
(Discovery DSC-18, 6 mL 500mg, Supelco, 
PA USA), which had previously been 
conditioned with sequential washes of 
methanol (6 mL), and deionised water (6 
mL). Thereafter, the columns were 
immediately washed with deionised 
water (water having a resistivity of at least 
18 MΩ cm-1 produced by passing singly 
distilled water through a Milli-Q Water 
Purification System; 50 mL), and eluted 
with methanol (5 mL) into a screw cap 
glass tube (Iwaki borosilicate glass; Asahi 
Techno Glass, Tokyo), and the resulting 
solution evaporated to dryness with 
nitrogen. 
Each sample was subjected to a crude 
fractionation process to isolate fractions 
containing non-polar chemicals (e.g. many 
of the persistent organic pollutants), the 
steroid hormones, and polar compounds.  
In short, the sample was re-suspended in 
a mixture of 3:1 hexane: dichloromethane 
(1 mL), and then loaded onto a florisil 
column (Strata FL-PR Florisil, 500 mg, 3 
mL; Phenomenex, USA) which had 
previously been conditioned with hexane 
(2.5 mL). After loading of the sample onto 
the column, the column was washed twice 
with a mixture of 3:1 hexane: 
dichloromethane (2.5 mL). The sample 
solution passing through the florisil 
cartridge at this time (the W fraction) was 
discarded. Thereafter, the cartridge was 
washed with a mixture of 1:9 acetone: 
dichloromethane (2 x 2.5 mL). The 
collected washes were combined and 
designated the FL fraction. The FL fraction 
was evaporated to dryness under 
nitrogen, resuspended with 10 µL DMSO, 
100 µL methanol and 890 µL of water, and 
frozen (-20°C) until subjected to a number 
of ELISA measurements, specifically for: 
• Estradiol  
• Estrone  
• Testosterone 
• Androstenedione 
• Total estrogenic activity (data not 
reported) 
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3.5.2 Measurement of estradiol  
Measurement of estradiol was conducted 
using a commercial ELISA kit, namely: 
• 17β-estradiol ELISA. Enzyme-linked 
immunosorbent assay for the in-vitro-
diagnostic quantitative determination of 
17β-estradiol in human serum and 
plasma (IBL, Hamburg, Germany) (IBL). 
Note: The IBL kit is principally sold for in 
vitro diagnostic use. However, the principle 
behind the kits is the same as much more 
expensive ELISA kits designed for 
environmental analysis, i.e. competitive 
binding. In short, a series of microtiter wells 
are coated with an antibody directed 
towards a unique antigenic site on the 
estradiol molecule. Estradiol within a 
sample competes with a known amount of 
conjugated estradiol standard for binding 
to the coated antibody. After a period of 
incubation, unbound conjugate is washed 
off the microtiter plate. The amount of 
bound estradiol conjugate is inversely 
proportional to the amount of estradiol in 
the sample. This is quantified by adding a 
colorometric substrate to the microtiter 
plate. After the addition of the substrate, 
the intensity of colour developed is 
inversely proportional to the concentration 
in the sample. 
Following sample filtration and extraction 
(see 3.5) measurement of hormone was 
conducted in accordance with the 
manufacturer’s instructions, using 
standards and reagents supplied in the kit. 
In short, standards, controls, and samples 
(25 µL of each; all duplicated) were 
dispensed individually into wells in the 96-
well microplate supplied with the kit. An 
enzyme conjugate (200 µL) was then added 
to each well. After mixing for 10 s, the plate 
was incubated uncovered for two hours at 
room temperature. Thereafter, each well of 
the plate was washed three times with 
diluted wash solution (400 µL) using a 
microplate washer (ATLANTIS 
Microplate Washer, ASYS Hitech GmbH, 
Salzburg, Austraia). Substrate solution 
(100 µL) was then added to each well, and 
the plate incubated for 15 minutes at room 
temperature. The enzymatic reaction was 
then stopped by adding stop solution (50 
µL), and the absorbance at 450nm in each 
well read by a microplate reader (UVM 
340 Microplate Reader, ASYS Hitech 
GmbH, Salzburg, Austria) within 10 
minutes of adding the stop solution. 
 
3.5.3 Measurement of estrone  
Measurement of estrone was conducted 
using a commercial ELISA kit, namely: 
• Estrone ELISA. Enzyme-linked 
immunosorbent assay for the direct 
quantitative determination of Estrone 
in human serum (IBL, Hamburg, 
Germany) (IBL). 
Following sample filtration and extraction 
(see 3.5) measurement of hormone was 
conducted in accordance with the 
manufacturer’s instructions, using 
standards and reagents supplied in the 
kit. In short, a working solution of the 
estrone conjugate was prepared by mixing 
equal volumes of estrone-biotin and 
avidin-HRP conjugates into the assay 
buffer (1:100 dilution). This mixture was 
allowed to stand for 20-25 minutes. 
Thereafter, aliquots (50 µL; in duplicate) 
of each standard, control, and sample was 
added individually into wells in the 96-
well microplate supplied with the kit. 
Conjugate working solution (100 µL) was 
added to each well, and the plate 
incubated for one hour at room 
temperature on a plate shaker (UVM 340 
Microplate Reader, ASYS Hitech GmbH, 
Salzburg, Austria). Each well of the plate 
was then washed three times with diluted 
wash solution (300 µL) using a microplate 
washer (ATLANTIS Microplate Washer, 
ASYS Hitech GmbH, Salzburg, Austraia). 
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TMB substrate solution (150 µL) was added 
to each well, and the plate incubated for 10-
15 minutes on the microplate shaker at 
room temperature. The enzymatic reaction 
was stopped by adding stop solution (50 
µL), and the absorbance at 450nm in each 
well read by a microplate reader (UVM 340 
Microplate Reader, ASYS Hitech GmbH, 
Salzburg, Austria) within 20 minutes of 
adding the stop solution. 
 
3.5.4 Measurement of testosterone  
Measurement of testosterone was 
conducted using a commercial ELISA kit, 
namely: 
• Testosterone ELISA. Enzyme-linked 
immunosorbent assay for the in-vitro-
diagnostic quantitative determination of 
testosterone in human serum and 
plasma (IBL, Hamburg, Germany) (IBL). 
Following sample filtration and extraction 
(see 3.5) measurement of hormone was 
conducted in accordance with the 
manufacturer’s instructions, using 
standards and reagents supplied in the kit. 
In short, standards, controls, and samples 
(25 µL of each; all duplicated) were 
dispensed individually into wells in the 96-
well microplate supplied with the kit. An 
enzyme conjugate (200 µL) was then added 
to each well. After mixing for 10 s, the plate 
was incubated uncovered for one hour at 
room temperature. Thereafter, each well of 
the plate was washed three times with 
diluted wash solution (400 µL) using a 
microplate washer (ATLANTIS Microplate 
Washer, ASYS Hitech GmbH, Salzburg, 
Austria). Substrate solution (200 µL) was 
then added to each well, and the plate 
incubated for 15 minutes at room 
temperature. The enzymatic reaction was 
then stopped by adding stop solution (100 
µL), and the absorbance at 450nm in each 
well read by a microplate reader (UVM 340 
Microplate Reader, ASYS Hitech GmbH, 
Salzburg, Austria) within 10 minutes of 
adding the stop solution. 
 
3.5.5 Measurement of androstenedione  
Measurement of androstenedione was 
conducted using a commercial ELISA kit, 
namely: 
• Androstenedione ELISA. Enzyme-
linked immunosorbent assay for the in-
vitro-diagnostic quantitative 
determination of androstenedione in 
human serum and plasma (IBL, 
Hamburg, Germany) (IBL). 
Following sample filtration and extraction 
(see 3.5) measurement of hormone was 
conducted in accordance with the 
manufacturer’s instructions, using 
standards and reagents supplied in the 
kit. In short, standards, controls, and 
samples (20 µL of each; all duplicated) 
were dispensed individually into wells in 
the 96-well microplate supplied with the 
kit. An enzyme conjugate (200 µL) was 
then added to each well. After mixing for 
10 s, the plate was incubated uncovered 
for one hour at room temperature. 
Thereafter, each well of the plate was 
washed three times with diluted wash 
solution (400 µL) using a microplate 
washer (ATLANTIS Microplate Washer, 
ASYS Hitech GmbH, Salzburg, Austria). 
Substrate solution (200 µL) was then 
added to each well, and the plate 
incubated for 15 minutes at room 
temperature. The enzymatic reaction was 
then stopped by adding stop solution (100 
µL), and the absorbance at 450nm in each 
well read by a microplate reader (UVM 
340 Microplate Reader, ASYS Hitech 
GmbH, Salzburg, Austria) within 10 
minutes of adding the stop solution. 
 
3.5.6 Calculation of ELISA results 
The average absorbance values for each 
set of standards, controls and samples 
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were calculated, and a calibration curve  
constructed by plotting the mean 
absorbance obtained from each standard 
against its concentration, using an 
automated method utilising 4 parameter 
logistics. The hormone concentration of 
samples was determined automatically 
from the calibration curves. Where samples 
had concentrations higher than that of the 
highest standard, the samples were diluted 
further and the concentration determined 
again. Sample dilution factors were taken 
into account when calculating hormone 
concentrations in the WWTP effluent.  
 
3.5.7 QA/QC for ELISA 
In order to verify the accuracy and 
precision of ELISA measurements a number 
of quality control and assurance procedures 
were undertaken. 
To verify calibration accuracy, check 
standards (i.e. standards from the kit run as 
samples) were run in duplicate on each 
ELISA plate during each ELISA test.  
• The ratio of nominal concentrations and 
result values were 87% (n=10, 71-113%) 
for 17β-estradiol, 86% (n=14, 62-139%) 
for estrone, 83% (n=6, 47-104%) for 
androstenedione, 87% (n=7, 72-109%) for 
testosterone, and 83% (n=6, 38-106%) for 
total estrogen (data not reported). 
To verify that the hormones in samples 
were passing through the sample 
preparation process quantitatively, and to 
verify that the hormones were found in the 
expected fractions, a number of recovery 
experiments were undertaken.  
In the first recovery trials, aliquots of kit 
standards were spiked into deionised water 
(500 mL) at three concentrations (17β-
estradiol, 0.5, 1.0, 5.0 ng/L; estrone, 0.4, 1.0, 
2.0 ng/L; testosterone, 0.3, 1.6, 3.2 ng/L;  and 
androstenedione, 1.0, 5.0, 10.0 ng/L, 
respectively) on three separate occasions, 
and the samples thereafter processed as 
per WWTP effluents.  
• The ratio of nominal concentrations 
and result values (i.e. recovery) were:  
• 17β-estradiol, 150% (CV, 12%) 
• 0.5 ng/L, 146%  
• 1.0 ng/L, 161% 
• 5.0 ng/L, 143% 
• Estrone, 118% (CV, 15%) 
• 0.4 ng/L, 112% 
• 1.0 ng/L, 115%  
• 2.0 ng/L; 126% 
• Testosterone, 197% (CV, 21%) 
• 0.3 ng/L, 243%  
• 1.6 ng/L, 164% 
• 3.2 ng/L, 184%   
• Androstenedione, 280% (CV, 18%) 
• 1.0 ng/L, 322%  
• 5.0 ng/L, 292% 
• 10.0 ng/L, 224%   
 
The second recovery trial examined the 
behaviour of our target hormones in a 
composite WWTP effluent (prepared by 
blending equal volumes of five WWTP 
effluents of the lowest hormonal activity 
and measured hormone concentrations).  
• The hormone concentrations in the 
composite sample (i.e. background 
levels) were both estimated from 
previous measurements and directly 
measured (n=2);  
• 17β-estradiol: estimated, 0.1 ng/L; 
measured, 0.3 ng/L 
• Estrone: estimated, 0.3 ng/L; 
measured, 0.3 ng/L 
• Testosterone: estimated, 0.2 ng/L; 
measured, 1.1 ng/L 
• Androstenedione: estimated, 0.0 
ng/L; measured, 1.4 ng/L  
Aliquots of kit standards were spiked into 
the composite WWTP effluent (500 mL), 
and the samples thereafter processed as 
per WWTP effluents. 
• Nominal concentrations (corrected for 
background hormone concentrations) 
 19
were: 17β-estradiol, 1.7 ng/L; estrone, 1.3 
ng/L; testosterone, 2.7 ng/L; and 
androstenedione, 2.9 ng/L, respectively. 
• Measured concentrations: 17β-estradiol, 
2.0 ng/L; estrone, 3.4 ng/L; testosterone, 
4.4 ng/L; and androstenedione, 6.9 ng/L, 
respectively. 
• Recoveries: 17β-estradiol, 118%; estrone, 
262%; testosterone, 162%; and 
androstenedione, 238%, respectively. 
In discussing hormone concentrations, data 
has not been corrected for recovery. 
 
3.6 Statistical analysis 
For statistical comparison, where the data 
did not conform to the stringent 
assumptions of parametric statistical 
methodologies, non-parametric statistical 
methodologies were used instead. For 
instance, the non-parametric analogue to 
the one way ANOVA (the Kruscal-Wallis 
analysis of variance), was used to assess for 
statistically significant differences in 
distributions within independent measures 
with more than two groups. If differences 
were detected, the Mann-Whitney test (the 
non-parametric equivalent of the t-test), 
was used for any subsequent post-hoc 
comparisons, or where a difference in the 
distributions in only two groups was 
investigated. Statistical analysis was 
conducted using SPSS version 14.0 for 
windows (SPSS Inc, Chicago) and 
XLStatistics Ver 5.0. 
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In Vitro Assays 
The molecular mechanism of estrogen 
action is the basis of all in vitro tests. The 
effects of endogenous and/or xenoestrogens 
are mediated by the estrogen receptor (ER). 
Inactive ERs exist in large complexes 
associated with heat shock proteins. When a 
compound binds to the ER, the heat shock 
proteins dissociate, and a conformational 
change activates the receptor and causes 
dimerisation. The resulting homodimer 
complex (HDC) shows high affinity for 
EREs (estrogen response elements) in the 
regulatory region of estrogen-inducible 
genes in the nucleus. After binding to the 
ERE, the HDC recruits transcription factors 
to the target gene promoter, leading to gene 
activation and transcription, and 
subsequent translation of RNA into the 
proteins that ultimately stimulate the 
observed responses. 
Several in vitro assays have been developed 
to screen the estrogenic activity of 
compounds in freshwaters or waste-water 
treatment plant effluents. 
• ER (Estrogen Receptor) competitive 
ligand binding assays quantify the 
ability of a compound to compete with 
estradiol (E2) to bind to the estrogen 
receptor (ER).  
• Cell proliferation assays measure the 
increase in numbers of estrogen 
sensitive cells. The most commonly 
used is the E-screen assay, in which 
the proliferation of human MCF-7 
breast cancer cells in response to 
estrogen is measured. 
• Reporter gene assays are based on 
genetically engineered human cancer 
cells or yeast cells into which specific 
DNA sequences called estrogen 
response elements (ERE) have been 
added and linked to a reporter gene. 
Essentially, the assay works by 
quantifying the ability of a chemical to 
stimulate ER-dependent 
transcriptional activity. In this assay, 
reporter gene expression is the result 
of a cascade of molecular events 
following receptor activation, 
considered to provide a more integral 
indication of the estrogenic activity of 
a compound than competitive ligand 
binding or cell proliferation assays, 
e.g. YES (yeast estrogen screen) assay, 
and the Yeast Two-Hybrid Assay that 
is used in this project.  
• Enzyme-linked immnosorbent assays 
(ELISAs) that depend on protein-
receptor binding are commonly used 
for measurement of EDC residues, and 
can be obtained as commercial kits.  
 
Yeast Two-Hybrid Assay 
This assay is based on the ligand-
dependent interaction of two proteins, a 
hormone receptor and a coactivator, and 
hormonal activity is detected by β-
galactosidase activity. 
Two expression plasmids, pGBT9-HRLBD 
and pGAAD424-TIF-2 are introduced into 
yeast cells, which carry a β-galactosidase 
reporter gene. Because the yeast strain 
harbours a GAL4 binding site upstream of 
a lacZ reporter gene, GAL4DBD-ER binds 
to 
 <Reporter gene assay> 
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the regulatory region of the lacZ gene. If 
GAL4DBD-ER interacts with GAL4AD-
coactivator, GAL4AD recruits the basal 
transcriptional machinery to the promoter 
region of the lacZ gene, resulting in 
production of β-galactosidase. Therefore, 
the β-galactosidase activity corresponds to 
the strength of interaction between ER and 
coactivator. The protein-protein interaction 
between ER and coactivator are strictly 
dependent on the presence of 17β-estradiol. 
 
Adapted from:  
1. WHO/IPCS (2002). Global assessment of 
the state-of-the-science of endocrine 
disrupters. Edited by: Damstra T, 
Barlow S, Bergman A, Kavlock R, Van 
Der Kraak G. World Health 
Organisation / International Program on 
Chemical Safety.  
2. Kinnberg K (2003). Evaluation of in 
vitro assays for determination of 
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Protection Agency, Danish Ministry of 
the Environment. 
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4. Results and Discussion 
The primary aim of this research was to 
measure estrogenic and androgenic 
activities of treated municipal wastewater 
at point of discharge from WWTP to the 
wider environment. Another aim was to 
compare discharge activities and 
concentrations of specific hormones within 
and between the different WWTP groups 
to assess which, if any, treatment process 
and location (i.e. temperature) was most 
effective at reducing the estrogenic and 
androgenic activity in discharges.  
• It is difficult to extrapolate results from 
one location (nation / state / region) to 
another (because of different project 
aims and methods used), although, 
where appropriate, we will make such 
comparisons to place our results in 
national and international context.  
In total, there are ~185 WWTPs in Victoria 
(not including plants under construction, 
in process of being decommissioned, and 
those for which no information was 
available).  
• Of these, 56% are in the north of the 
state (defined as being north of the 
Great Dividing Range), and 44% in the 
south. 
• 124 (67%) are lagoon based plants, 
including those reporting treatment 
using maturation lagoons, facultative 
lagoons, oxidation ponds. Of these 
lagoon-based plants, two-thirds are in 
the north of the state. 
• 61 (33%) are mechanical treatment 
plants, including those using various 
forms of activated sludge processes, 
extended aeration/flocculation 
technology, and trickle filters. Of these 
mechanical plants, two-thirds are in the 
south of the state. 
The annual outflows of the forty-five 
WWTPs we surveyed in this study are as 
varied as that determined for Victoria’s 
WWTPs as a whole, i.e. there is a five order 
of magnitude difference in reported annual 
outflow between the smallest and largest 
plants (based on annual flows) (Figure 4.1). 
• There is no difference in annual flow 
between the six treatment groups.  
 
4.1 Androgenic activity and androgen 
concentrations 
In the Winter 2006 survey, no sample 
produced a response in the androgen assay 
(hAR assay) (Figure 4.2). The results of the 
concurrent toxicity assay suggest that a 
lack of assay response was related to lack 
of androgenic compounds, rather than the 
direct toxic effect of the effluent, since most 
samples were non-toxic or weakly-toxic 
(IC50 (C.R.) ≥ 400; Figure 4.3).  
• In other words, lack of response by the 
hAR assay was not caused by the 
samples killing off the yeast, but rather 
suggested that either (a) androgenic 
activity was too low for the bioassay, 
and/or (b) the compounds are in 
fractions not studied.  
That the lack of androgenic response is due 
to lack of androgens in the sample is in 
part assured because we measured 
androgenic activity in all three fractions 
(W, FL and RM), and found no activity in 
any fraction; and in part assured because 
the nature of the testing itself, i.e. the use 
of positive controls in the assay. In this 
case, the assay responded normally to the 
two positive controls used, namely 
dihydrotestosterone and 11-keto-
testosterone.  
That the sample preparation process does 
not remove steroid hormones from the 
sample was in part assured through early 
QA/QC procedures in which the hormones 
were tracked through the separation steps 
(data not presented), and thereafter the use 
of spiked composite WWTP effluent to  
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Figure 4.1 Summary of annual outflows for WWTP surveyed.  
• Note: logarithmic scale; data as reported by water authorities 
directly to project team, or indirectly through other publications; 
AS, activated sludge-based WWTP; AS(EA), treatment based on 
extended aeration-flocculation; L, lagoon-based WWTP; N, 
north; S, south; , arithmetic mean; line within data boxes, data 
median; upper and lower boundaries of boxes, 75th and 25th 
percentile of data. 
 
 
 
Figure 4.2 Summary of androgenic activity of Winter 2006 samples.  
• As measured by hAR assay. 
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Figure 4.3 Summary of Winter 2006 sample toxicity.  
• Note: the higher the IC50 (C.R.), the lower the toxicity. Data for 
FL fraction; AS, activated sludge-based WWTP; AS(EA), 
treatment based on extended aeration-flocculation; L, lagoon-
based WWTP; N, north; S, south; , arithmetic mean; line within 
data boxes, data median; upper and lower boundaries of boxes, 
75th and 25th percentile of data. 
 
 
Toxicity of samples
(photobacterium test, Summer 2007)
0
100
200
300
400
500
AS (N) AS (S) AS(EA)
(N)
AS(EA)
(S)
L (N) L (S)
Location
I
C
5
0
 
(
C
.
R
.
)
 
 
Figure 4.4 Summary of Summer 2007 sample toxicity.  
• Note: the higher the IC50 (C.R.), the lower the toxicity. Data for 
FL fraction; AS, activated sludge-based WWTP; AS(EA), 
treatment based on extended aeration-flocculation; L, lagoon-
based WWTP; N, north; S, south; , arithmetic mean; line within 
data boxes, data median; upper and lower boundaries of boxes, 
75th and 25th percentile of data. 
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Figure 4.5 Summary of testosterone concentrations in Winter 2006 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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Figure 4.6 Summary of testosterone concentrations in Summer 2007 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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Figure 4.7 Summary of androstenedione concentrations in Winter 
2006 samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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Figure 4.8. Summary of androstenedione concentrations in Summer 
2007 samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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assess analyte recovery (see Section 3.5.6). 
In this latter case, testosterone and 
androstenedione were quantitatively 
recovered in the FL fraction (if anything, 
the ELISA system overestimates 
testosterone and androstenedione 
concentrations). 
• Because none of the Winter 2006 
samples produced a response in the 
hAR assay, this test was not conducted 
on Summer 2007 samples. 
Measurement of testosterone and 
androstenedione concentrations by ELISA 
suggests that there were indeed androgens 
present in both the Winter 2006 and 
Summer 2007 samples, but at 
concentrations generally below 3 ng/L 
(testosterone; Figure 4.5, 4.6) and below 10 
ng/L (androstenedione; Figure 4.7, 4.8), 
and hence below the estimated limit of 
determination of the assay.   
There are no statistical differences in the 
concentration of either testosterone or 
androstenedione within (i.e. north or south 
of state) or between treatments in either 
Winter 2006 or Summer 2007, and no 
statistical differences in the concentration 
of either androgen between Winter 2006 
and Summer 2007.  
The low levels of testosterone observed in 
our study are consistent with Fernandez et 
al. 1 and Esperanza et al. 2, neither of whom 
reported measurable amounts of 
testosterone in their surveys of Canadian 
and Spanish WWTPs, respectively.  
The low levels of testosterone and 
androstenedione observed in our study are 
also broadly consistent with recent reports 
by Tan et al. 3 of low ng/L concentrations 
of androsterone and etiocholanolone 
(metabolites of testosterone and 
androstenedione) in the effluent from five 
WWTPs in South East Queensland 
employing activated sludge as the 
secondary biological treatment step (<BDL 
- ~ 26 ng/L).  
• The rationale for choosing to monitor 
androsterone and etiocholanolone 
concentrations rather than testosterone 
and androstenedione is not explored by 
Tan et al. 3, but it is perhaps not 
unreasonable to assume that low levels 
of these major metabolites in the 
effluents would have translated into 
low levels of parent compound in the 
effluents. 
The lack of androgenic activity and the low 
levels of testosterone and androstenedione  
(or their metabolites) observed in our 
study is, however, somewhat inconsistent 
with reports by Leusch et al. 4 of high, and 
highly variable, levels of androgenic 
activity in the final effluents of thirteen 
WWTPs in southern Queensland (12 
suspended film/activated sludge plants, 1 
trickle filter-based plant) and two WWTPs 
in Canterbury, New Zealand (one trickle 
filter-based plant, and one oxidation pond 
treatment system) (<6.5–736 ng/L 
testosterone equivalents).  
• Chapman et al. 26 claim these levels are 
similar to those reported for WWTPs in 
the United Kingdom (< 113 - 4000 ng/L 
DHT equivalents in a yeast assay, 5 and 
34-635 ng/L (DHT equivalents in a yeast 
assay). 6  
• However, Kirk et al. 5 actually report 
that androgenic activity was below their 
MDL (<113 ng/L DHT equiv.) in all bar 
one effluent, and the high levels of 
androgenic activity reported by Thomas 
et al. 6 were for effluents receiving only 
primary treatment (cf. the suspended 
growth/activated sludge plants in 
Leusch et al.’s 2006 survey). 4 Andro-
genic activity in the effluent from the 
activated sludge plants in Thomas et 
al’s survey were < 23 ng/L DHT equiv. 6 
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We must, however, be very careful not to 
make too much of these comparisons for a 
number of reasons, namely: 
• The different target analytes and 
experimental protocols of the studies, 
including those associated with sample 
handling and preparation, and the 
different methods used to determine 
androgenic activity and hormone 
concentrations. 
• That, nationally and internationally 
very little is known of androgenic 
activity and the levels of specific 
androgens in WWTP discharges 
(particularly cf. our knowledge of 
estrogens). Indeed, until recently, the 
only papers quoted when discussing 
androgenic activities in WWTP effluents 
were those of Kirk et al. 5 and Thomas et 
al. 6 
In short, given the paucity of information 
available, nationally or internationally, any 
discrepancies between Victorian values 
and those in southern Queensland may not 
be real at all, rather the wide variability in 
hormonal activity observed (particularly in 
southern Queensland) may simply reflect 
reality – there is significant variation in 
androgenic activity and the concentration 
of specific androgens in WWTP effluents.  
• More research needs to be done to 
verify the androgenic activity and 
specific hormone/metabolite levels 
reported in these studies. 
Little is known about the effect of exposure 
of fish and other aquatic organisms to 
androgenic chemicals originating from 
WWTPs, although some studies have 
shown masculinization of mosquito fish 
exposed to paper mill effluents containing 
ng/L levels of the steroid androstenedione  
7 , 8. 
• More research needs to be done to 
determine if the androgenic activity 
reported in recent Australian studies is 
sufficient to induce a physiological 
effect in exposed fish. 
 
4.2 Estrogenic activity and estrogen 
concentrations 
Almost all of the effluents examined in 
both the Winter 2006 and Summer 2007 
surveys showed estrogenic activity, to a 
greater or lesser extent, in both the hER 
and mER assays (Figures 4.9 - 4.12).  
• Winter 2006 
o  hER, not detected – 7.9 ng/L EEQ; 
o  mER, not detected – 11 ng/L EEQ 
(with one sample 61.5 ng/L EEQ). 
• Summer 2007 
o  hER, not detected – 16 ng/L EEQ; 
o  mER, not detected – 18 ng/L EEQ. 
In both Winter 2006 and Summer 2007, 
estrogenic activity is correlated with 
sample toxicity (much more strongly so in 
Summer 2007), i.e. low activity, high 
toxicity.  
• Consequently, in discussing the levels 
of estrogenic activity observed, we must 
consider that a lack of assay response, 
or a low response, may be related to the 
direct toxic effect of the effluent, i.e. 
no/low response because the yeast is 
being adversely affected by toxic 
components in the sample.  
There are no statistical differences in 
estrogenic activity within (i.e. north or 
south of state) or between treatments in 
samples collected in the Winter 2006 
survey. There are also no statistical 
differences in estrogenic activity within 
treatments (i.e. between samples collected 
from the north of the state and those 
collected from the south of the state) in the 
Summer 2007 survey, regardless of 
treatment type. However, there was a 
statistically significant difference in 
estrogenic activity between activated 
sludge-based (AS) plants and  
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Table 4.1 A comparison of estrogenic activity reported for Victorian wastewater treatment plant effluents with that reported elsewhere in 
Australia and New Zealand and internationally studies.  
Location Method Concentration  Reference 
  (ng/L EEQ)  
Canada YES N.D. - 96 Servos et al., 2005 9 
China Recombinant yeast assay 0.05 – 0.5 Ma et al., 2007 10 
Finland Bioluminescent yeast assay 4 - 7 Salste et al., 2007 11  
Germany  < 1 Andersen et al., 2003 12 
Germany YES 65.9 ± 10.4 Pawlowski et al., 2004 13 
Japan Yeast assay 5 - 15 Matsui et al., 2000 14 
Sweden YES <0.1-15 Svenson et al., 2003 15 
Switzerland YES 0.1-90 Rutishauser et al., 2004 16 
USA YES 44-151 Tilton et al. 2002 17 
USA E-screen 1- 2 Shappell, 2006 18 
Australasia 
Northern Territory YES 0.098 ± 0.01 Hogan et al., 2005 19 
Western Victoria Y2h a N.D. - 55 Mispagel et al., 2005 20 
Western Victoria Y2h b N.D. - 42 Mispagel et al., 2005 20 
Southern Queensland ER c < 0.75 Leusch, 2005 21 
Southern Queensland, New Zealand ER c <1 - 4.2 Leusch, 2006 4 
Southern Queensland E-screen <1 - 67.8 Tan et al., 2007 3 
Southern Victoria Y2h a <0.5 - 45 Allinson, unpublished 
Southern Victoria Y2h b <0.5 – 7.9 Allinson, unpublished 
New Zealand ER d 50 Bandelj et al., 2006 22 
Victoria (winter) Y2h a N.D. - 61.5 This study 
Victoria (summer) Y2h a N.D. - 18 This study 
• EEQ, estradiol equivalents; a, yeast two hybrid assay incorporating Japanese medaka estrogen receptor; b, yeast two hybrid assay incorporating human estrogen receptor; 
c, estrogen receptor binding assay utilising receptors isolated from sheep; d , estrogen receptor binding assay utilising receptors isolated from rainbow trout liver; N.D., 
not detected. 
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Figure 4.9 Summary of estrogenic activity (hER) in Winter 2006 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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Figure 4.10 Summary of estrogenic activity (hER) in Summer 2007 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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Figure 4.11 Summary of estrogenic activity (mER) in Winter 2006 
samples. 
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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Figure 4.12 Summary of estrogenic activity (mER) in Summer 2007 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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lagoon-based (L) WWTPs  in Summer 2007 
(mER assay, p<0.05). There was also a 
statistically significant difference in 
estrogenic activity between Winter 2006 
and Summer 2007, with higher activity in 
Winter 2006 (p<0.05).  
In both Winter 2006 and Summer 2007, 
hER and mER estrogenic activity is very 
strongly correlated. In other words, 
although the estrogenic activity as 
measured by hER is generally lower than 
that measured by mER, where there is high 
hER activity there is also high mER 
activity. 
• The hER assay is more sensitive to 
estradiol (and estradiol-related) 
compounds than the mER assay. On the 
other hand, the mER assay is somewhat 
more sensitive to xenoestrogens such as 
alkylphenols.   
The estrogenic activity observed in this 
study is comparable with that of Mispagel 
et al. 20, and that recently reported by Tan 
et al. 3 in Australia and New Zealand 
(Table 4.1). In the latter case, the estrogenic 
activity of effluent from five municipal 
wastewater treatment plants (WWTPs) in 
South East Queensland, Australia was 
determined using E-Screen assays at 
between <1–14.8 ng/L EEQ (with the 
exception of one effluent sample which 
was at 67.8 ng/L EEQ). 
On the whole, the levels of estrogenic 
activity observed in this study were 
consistent with that observed in the 
northern hemisphere, e.g. in Japan (5-15 
ng/L EEQ) 12 the USA (21-147 ng/L EEQ) 15 
Sweden (<0.1-15 EEQ) 13 and Switzerland 
(<1-90 ng/L EEQ) 14 respectively (Table 4.1).  
Estradiol and estrone were observed in 
almost all of the effluents examined in both 
the Winter 2006 and Summer 2007 surveys, 
to a greater or lesser extent (Figures 4.13 - 
4.16).  
• Winter 2006 
o estradiol, <0.1 – 12.4 ng/L. 
o estrone, <0.2 – 16.8 ng/L. 
• Summer 2007 
o estradiol, <0.1 – 18.5 ng/L. 
o estrone, <0.1 – 32.0 ng/L. 
There are no statistical differences in 
estradiol or estrone concentrations within 
(i.e. north or south of state) or between 
treatments in samples collected in the 
Winter 2006 survey. There are also no 
statistical differences in estrone 
concentration within treatments (i.e. 
between samples collected from the north 
of the state and those collected from the 
south of the state) in the Summer 2007 
survey, regardless of treatment type. 
However, in the Summer 2007 survey, 
there was a statistically significant 
difference in estradiol concentration within 
treatments for the extended aeration 
(AS(EA)) and lagoon (L) groups (p<0.05). 
For both estradiol and estrone, there was a 
statistically significant difference in 
concentration between treatments for the 
activated sludge-based (AS) plants and 
lagoon-based (L) plants (p<0.05). Finally, 
estradiol and estrone concentrations were 
higher in the Winter 2006 survey than in 
the Summer 2007 survey (p<0.05), 
particularly in the lagoon-based WWTP 
effluents. 
The estradiol and estrone concentrations 
observed in this study are comparable 
with those seen elsewhere in Australia and 
New Zealand (e.g. 23,24 ), and at the lower 
end of the range of concentrations reported 
internationally (Table 4.2, 4.3), particularly 
for estrone. 
Estrogens, such as estradiol, are excreted 
by humans as inactive glucuronide or 
sulfonate conjugates. Microbial activity in 
the sewerage system and treatment plants 
results in deconjugation of these 
compounds. Deconjugation causes the 
hormones to resume their active form. 
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• The higher estrogenic activity / estrogen 
concentrations seen in the Winter 
survey may have been, in part, caused 
by deconjugation during water storage 
in lagoons (including those associated 
with many activated sludge-based 
WWTPs) leading to an increase in 
measured estrogenic activity/estrogen 
concentration in the discharged water. 
• The lower estrogenic activity / estrogen 
concentrations seen in the Summer 2007 
survey may have been, in part, caused 
by much shorter retention times in the 
WWTP systems, in and of itself caused 
by the off-site demand for the water 
(e.g. by irrigators). 
• Servoc et al. 10 noted that, while there 
was no statistical difference, the lagoons 
that had extremely long hydraulic 
retention time (HRT) and solids 
retention time (SRT) had consistently 
high removal of estrogens and 
estrogenic activity.  
• The current study used a limited 
number of grab samples of the final 
effluent (environmental discharge) of 
many different plants with a wide 
variety of treatment and process 
characteristics. Additional, controlled 
studies are needed to more fully explore 
the potential relationship between 
extended HRT and SRT on removal of 
estrogens. 
In its early stages, the project was faced 
with a choice, whether to conduct in-depth 
investigations on a limited number of 
WWTPs (i.e. from raw influent to treated 
effluent), or to take a broader look at a 
number of WWTPs (i.e. measure hormonal 
activity at a large number of locations). 
After much discussion, the Project Steering 
Committee decided to take the latter 
approach, in part justifying the decision on 
the paucity of information on hormonal 
activity of Victorian WWTP discharges. 
Consequently, we did not collect raw 
wastewater samples, or samples through 
treatment trains, and we are thus unable to 
determine the estrogen and androgen 
removal efficiencies of the WWTP 
investigated. 
Although there have been few detailed 
comparative studies, secondary treatment 
using suspended solids processes is 
considered more effective at reducing the 
estrogenic activity in wastewater than 
biological filter-based treatment 25, 
removing more than 90% of the activity in 
primary-treated wastewater. Leusch et al. 
21, 4 suggest activated sludge treatment is 
particularly effective, removing >99% of 
the estrogenic activity in the raw 
wastewater. Braga et al. 23 suggest lower 
removal efficiencies, but still report 
activated sludge treatment removes more 
than 85% of E1 and E2.  
The removal efficacy of biological filter-
based treatment plants, such as trickling 
filters, appears to be much more variable. 
Chapman et al. 26 report a trickling filter 
WWTP in southern Queensland removed 
92% of the estrogenic activity, while a New 
Zealand trickling filter WWTP actually 
caused an increase in estrogenic activity. 
Johnson et al. 25 suggested that removal 
efficiencies of 10 biological filter plants in 
the U.K. were nearer 30% (for estrogenic 
activity). 
• While treatment efficiency of activated 
sludge plants may be high, if the 
hormonal activity of the raw 
wastewater is high, then discharge 
activity may still have unacceptably 
high levels of hormonal activity (from 
an aquatic risk perspective). 
• From an environmental risk assessment 
perspective, the highest priority is not to 
know how good a particular plant, or 
type of system is at reducing the levels 
of a contaminant, but rather to know the 
levels in the waters that are discharged 
to the environment.  
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Chapman et al. 26  suggest that the poor 
efficacy of the New Zealand trickling filter 
plant (cf. the plant in southern 
Queensland) may be related to the lower 
ambient air temperature (4-14ºC at the 
New Zealand plant compared with 14-21 
ºC at the Queensland plant). Chapman et 
al. 26 also suggest that the slightly higher 
estrogenic activity seen in effluents in New 
South Wales and Victoria (cf. southern 
Queensland) is also likely due to the colder 
climate in the southern states (resulting in 
lower removal efficiency of estrogenic 
chemicals). 
The recent results by Tan et al 3  (<1–67.8 
ng/L EEQ; Table 4.1) in part negate the 
hypothesis put forward by Chapman et al. 
26 because they indicate that estrogenic 
activity in southern Queensland may, in 
fact, not be much different from that 
observed in Victoria. However, Tan et al’s 
results were unavailable when we began 
this study, so to address the temperature 
hypothesis, in this study we collected 
ambient temperature information for the 
nearest weather stations to our sampling 
sites for the months in which our samples 
were collected. 
• In August 2006, the southern WWTPs 
were, on average, several degrees 
warmer than their counterparts in the 
north of the state, yet there was no 
difference in hormonal activity, or 
hormone concentrations within 
treatments (north cf. south). 
• In February/March 2007, the northern 
WWTPs were, on average, some 12 
degrees warmer than their counterparts 
in the south of the state, yet hormonal 
activity, and hormone concentrations 
within treatments were significantly 
different (north higher than south). 
• The results suggest that ambient 
temperature may have some influence 
on hormonal activity of the WWTP 
discharges studied, but that ambient 
temperature is only one of a number of 
potential influences, and indeed may 
not be an adequate surrogate for actual 
water temperature in the WWTP 
systems. Further work assessing the 
influence of actual effluent temperature 
on hormonal activity is required.  
 
 
4.3 Potential Environmental Risk 
The list of trace contaminants found in 
wastewater is long. However, in general, 
natural hormones (e.g. E1, E2, and E3) are 
considered the major contributors to the 
estrogenic activity observed in most 
sewage effluents, and subsequently in the 
receiving water. In the northern 
hemisphere, fish exposed to WWTP 
effluent (or wastewater contaminated 
water in rivers) have been found to exhibit 
a wide array of biochemical and 
physiological effects. Of these, perhaps the 
most often quoted are abnormally high 
levels of vitellogenin (Vtg) in males, and 
high incidences of intersexuality in 
gonochoristic species 27. 
• Vitellogenin is a protein synthesized by 
oviparous vertebrates under estrogenic 
stimulation 28, and hence normally only 
produced in significant quantities in 
females. Exposure to xenoestrogens can 
induce Vtg production in males 29, 
although it is unclear if high levels of 
Vtg in males have reproductive 
impacts.  
• Intersex in fish is primarily 
characterized by the presence of both 
male and female sex cells in the gonads 
of an individual (ovotestis).  
The risk to fish of exposure to 
environmental estrogens has been 
demonstrated in both the field and 
laboratory. 
• Jobling et al. 30 found a high incidence of 
intersexuality in wild populations of 
roach in eight rivers in the UK, 
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especially those fish captured 
downstream of WWTP outfalls. Similar 
findings have been reported in Danish 
streams receiving WWTP effluent 31. 
Such intersex has been shown to be 
caused in a dose-dependent manner 32.  
• Male mosquito fish (Gambusia holbrooki) 
collected in wastewater-contaminated 
water in New South Wales have shown 
evidence of feminization of secondary 
sexual characteristics consistent with 
exposure to estrogenic chemicals 33. 
One of the main aims of this study was to 
provide water authorities with an 
understanding of the range of estrogenic 
activity in Victorian WWTP effluents, and 
a consideration of potential impact in 
receiving waters. From an aquatic 
environmental perspective, one might 
consider it appropriate to look at the data 
produced by the assay incorporating a fish 
estrogen receptor (mER assay), particularly 
if the intention is to protect fish and other 
organisms in receiving waters. However, 
although such in vitro assays are useful as 
screening tools for monitoring studies, 
they are a simplification of the in vivo 
situation, i.e. although they are living 
systems in vitro tests are, to put it simply, 
not fish, and do not address effects that 
result from multiple mechanisms or take 
into account processes such as 
bioavailability, toxicokinetics, metabolism 
or cross-talk between biological pathways. 
Unless, and until, we can address the latter 
using in vivo tests, risk can only partially 
be addressed by comparing specific 
chemical concentrations in the effluent 
with classical toxicological experiments. In 
this case, estradiol is the most appropriate 
chemical to use. 
• The lowest level of E2 at which 
physiological effects have been 
observed in fish (rainbow trout; 
reduced semen volume, sperm density 
and sperm fertility) is 1 ng/L. 
(Lahnsteiner et al., 2006; Table 4.4) 34. 
• The next lowest level at which 
physiological effects (intersex) have 
been observed in fish (medaka) is 8.7 
ng/L E2 (Seki et al., 2005) 35. 
• The lowest level at which induction of 
Vtg has been observed in laboratory 
studies using fish (trout) is 1 ng/L E2 
(Purdom et al., 1994; Hansen et al., 1998; 
Table 4.5) 36, 29.  
Apart from some of the southern lagoon 
systems, for the most part estradiol 
concentrations were above 1 ng/L E2 and 
below 10 ng/L E2. One assumption 
commonly made is that WWTP discharges 
will be diluted significantly in the 
receiving environment. This may not be 
appropriate in some circumstances, e.g. 
where the discharge represents all, or most 
of, the environmental flow in a waterway, 
or where discharges are to enclosed water 
bodies (e.g. lakes). In such cases, there may 
be significant risks to aquatic wildlife. 
• The levels of estrogenic activity seen in 
our Victorian WWTPs are likely to be an 
environmental risk if WWTP discharge 
represents a major component of stream 
flow.  
• In this broad-brush and simplistic 
assessment of risk, no account is taken 
of the potential of low concentrations of 
highly active compounds (such as 
ethinyl estradiol) to increase the 
perceived risk of the effluents, or of the 
additive effects of mixtures of 
chemicals, i.e. the chemical cocktail 
found in the effluent may induce effects 
equivalent to the sum of the effects seen 
by individual chemicals in the mixture 
at equivalent concentrations. 
In short, this study provides some 
reassurance that, for the most part, 
Victorian environments are probably not at 
risk from the steroid hormones in WWTP 
effluents (at least, acting on their own), but  
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Table 4.2 A comparison of estradiol concentrations in Victorian wastewater treatment plant effluents with that reported elsewhere in 
Australasia and internationally.  
 
Location Method Concentration  Reference 
  (ng/L)  
Canada GC/MS/MS N.D. – 64 Ternes et al., 1999 37 
Canada GC/MS N.D. – 13.9 Lishman et al., 2006 38 
Canada GC/MS ~3 - ~15 * Fernandez et al., 2007 1 
Canada  0.2 – 14.7 Servos et al., 2005 9 
Denmark  <1 – 4.5 Andersen et al., 2004 39 
France GC/MS 4.5 – 8.6 Cargouët et al., 2004 40 
Germany GC/MS/MS N.D. – 3 Ternes et al., 1999 37 
Germany GC/MS <0.1 – 15 Kuch & Ballschmiter, 2001 41 
Germany GC/MS < 1 ng/L Andersen et al. 2003 12 
Germany  <0.5 – 1.5 Hansen et al., 1998 29 
Germany ELISA 3.1 - 51 Hintemann et al., 2006 42 
Germany GC/MS/MS <0.5 - 1 Joss et al., 2004 43 
Italy  LC/MS/MS N.D. - 7 Johnson et al., 2000 44 
Italy  LC/ESI/MS/MS 0.35 - 35 Baronti et al., 2000 45 
Japan LC/MS/MS 0.3 – 2.5 Isobe et al., 2003 46 
Japan LC/MS/MS N.D. - 11 Komori et al., 2004 47 
Japan ELISA 7 - 9 Matsui et al., 2000 14 
Japan GC/MS ~0.5 - ~15 * Nakada et al., 2006 48 
Netherlands GC/MS/MS < 0.6 - 12 Belfroid et al., 1999 49 
Netherlands  LC/MS/MS N.D. - 12 Johnson et al., 2000 44 
Spain GC/MS/MS <1 Carballa et al., 2004 50 
Sweden GC/MS 1.1 Larsson et al., 1999 51 
Switzerland GC/MS <0.5–6.4 Rutishauser et al., 2004 16 
• *, calculated from author’s manuscript; N.D., not detected. 
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Table 4.2 (contd) 
 
Location Method Concentration  Reference 
  (ng/L)  
Taiwan LC/MS/MS N.D. – 44.5 Chen et al., 2007 52 
U.K. GC/MS 2.7 - 48 Desbrow et al., 1998 53 
U.K. GC/MS/MS <0.3 Fawell et al., 200154 
U.K. GC/NCI/MS 1.6-7.4 Xiao et al., 200155 
U.K.  4.0 - 48 Hansen et al., 1998 29 
USA GC/NCI/MS < 1 - 6 Drewes et al., 2005 56 
USA ELISA 0.6 – 6.2 Drewes et al., 2005 56 
USA GC/MS 1.0 ± 0.4  Esperanza et al., 2007 2 
USA LC/MS/MS 0.2- 0.26 Reddy et al., 2005 57 
Australasia 
Southern Queensland - <5 Chapman, 2003 58 
Southern Queensland GC/MS 4.7 Khan, 2004 59 
New South Wales  GC/MS BDL - 12 Braga, 2005a, 2005b 23, 60 
Queensland E-Screen <0.75 Leusch, 2005 21 
New Zealand GC/MS Trace - 14.8 Sarmah, 200624 
Vic (winter) ELISA N.D. – 12.4 This study 
Vic (summer) ELISA N.D. – 18.5 This study 
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Table 4.3 A comparison of estrone concentrations in Victorian wastewater treatment plant effluents with that elsewhere in Australasia and 
internationally.  
 
Location Method Concentration  Reference 
  (ng/L)  
Canada GC/MS/MS N.D. – 48 Ternes et al., 1999 37 
Canada GC/MS 16 - 49 Lishman et al., 2006 38 
Canada  1–96 Servos et al., 2005 9 
Denmark  <2 - 11 Andersen et al., 2004 39 
France GC/MS 6.2 – 7.2 Cargouët et al., 2004 40 
Germany GC/MS < 1 ng/L Andersen et al., 2003 12 
Germany GC/MS/MS N.D. – 70 Ternes et al., 1999 37 
Germany GC/MS <0.1 – 15 Kuch & Ballschmiter, 2001 41 
Germany  <1 Hansen et al., 1998 29 
Germany GC/MS/MS <0.5 – 8.6 Joss et al., 2004 43 
Italy  LC/MS/MS N.D. - 7 Johnson et al., 2000 44 
Italy  LC/ESI/MS/MS 2.5 - 82 Baronti et al., 2000 45 
Japan LC/MS/MS N.D. - 180 Komori et al., 2004 47 
Japan GC/MS ~3 - ~100 * Nakada et al., 2006 48 
Japan GC/MS 5.9 - 60 Nakamura et al., 2007 61 
Netherlands GC/MS/MS < 0.4 - 47 Belfroid et al., 1999 49 
Netherlands  LC/MS/MS <0.4 - 47 Johnson et al., 2000 44 
Spain GC/MS/MS 4.4 Carballa et al., 2004 50 
Sweden GC/MS 1.1 Larsson et al., 1999 51 
Switzerland GC/MS 4–50.5 Rutishauser et al., 2004 16 
Taiwan LC/MS/MS N.D. – 48.6 Chen et al., 2007 52 
U.K. GC/MS 1.4 - 76 Desbrow et al., 1998 53 
U.K. GC/MS/MS <0.3 Fawell et al., 2001 54 
• *, calculated from manuscript data; N.D., not detected. 
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Table 4.3 (contd) 
 
Location Method Concentration  Reference 
  (ng/L)  
U.K. GC/NCI/MS 6.4 - 29 Xiao et al., 200155 
U.K.  1.4 - 76 Hansen et al., 1998 29 
USA GC/NCI/MS 0.6 – 50.4 Drewes et al., 2005 56 
USA GC/MS 9.0 ± 0.7 Esperanza et al., 2007 2 
USA LC/MS/MS 0.7- 0.72 Reddy et al., 2005 57 
Australasia 
Southern Qld - <13 Chapman, 2003 58 
NSW GC/ECD, HPLC, ELISA 13 - 430 Li, 2004 62 
Qld GC/MS 92 Khan, 2004 59 
NSW GC/MS BDL - 54 Braga, 2005a, 2005b 23, 60 
New Zealand GC/MS Trace - 84.7 Sarmah, 2006 24 
Vic (statewide, winter) ELISA N.D. – 16.8 This study 
Vic (statewide, summer) ELISA N.D. – 32.0 This study 
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Figure 4.13 Summary of estradiol concentrations in Winter 2006 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
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Figure 4.14 Summary of estradiol concentrations in Summer 2007 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
12 15 18 12 
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Figure 4.15 Summary of estrone concentrations in Winter 2006 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
Estrone concentration
(Summer 2007)
0
3
6
9
12
15
18
AS (N) AS (S) AS(EA)
(N)
AS(EA)
(S)
L (N) L (S)
Location
n
g
/
L
 
 
 
Figure 4.16 Summary of estrone concentrations in Summer 2007 
samples.  
• Data for FL fraction; AS, activated sludge-based WWTP; 
AS(EA), treatment based on extended aeration-flocculation; L, 
lagoon-based WWTP; N, north; S, south; , arithmetic mean; line 
within data boxes, data median; upper and lower boundaries of 
boxes, 75th and 25th percentile of data. 
18.5 32 
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 Table 4.4 Selected studies highlighting reproductive effects in fish exposed in laboratory to estradiol. 
 
Fish species Exposure Duration 
& LOEC (ng/L) 
Life stage & Effect Reference 
Medaka (Oryzias latipes) 2 generations; 8.7 P.H. to F1 generation; abnormal sex differentiation Seki et al., 2005 35 
 1 month; 10  P.H.; all female fish Nimrod & Benson, 1998 63 
 100 days; 10 P.H..; 10% of males with testis-ova Metcalfe et al., 200164 
 20 days; 33.5 P.H.; testis-ova observed in male fish after 14 days Hirai et al., 2006 65 
 21 days; 29.3 R.A.; males with testis-ova Kang et al., 2002 66 
 2 weeks; 817  R.A.; reduced egg production and decreased egg hatch Shioda & Wakabayashi, 2000 67 
 6 days; 15000 E & Y; more phenotypical males than females, intersex 
gonads 
Koger et al., 2000 68 
Java-medaka (Oryzias javanicus) 6 months; 16 P.H.; fecundity lower than that of control Imai et al., 2005 69 
Fathead minnow (Pimephales 
promelas) 
19 days; 120 R.A.; inhibition of egg production Miles-Richardson et al., 1999 70 
 3 weeks; 50 A.M.; reproductive failure in competition with 
unexposed males 
Martinovic et al., 2007 71 
Goldfish (Carassius auratus) 
24-28 days; 1000 R.M.; reduced GSI and courting; fewer males with 
tubercles 
Bjerselius et al., 2001 72 
Guppy (Poecilia reticulata) 26-36 days;  850 * R.A.; no adverse effects on reproduction or young Kinnberg et al., 2003 73 
 4 weeks; 10000 * Complete inhibition of male sexual behaviour  
Rainbow trout (Oncorhynchus 
mykiss) 
50 days; 1 Reduced semen volume, sperm density and sperm 
fertility 
Lahnsteiner et al., 2006 34 
Carp (Cyprio cyprio) 3 months; 1000 R.M.; reduced GSI, no milt production Gimeno et al., 1998b 74 
 2 months; 9000 J.M.; all juvenile males developed into females Gimeno et al., 1998a 75 
• P.H., post-hatch; R.A., reproductive adults; R.M., reproductive males; A.M., adult male; J.M., juvenile male; E, eggs; Y, young; *, single concentration. 
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Table 4.5 Selected studies highlighting Vtg expression in fish exposed in laboratory to estradiol. 
 
Fish species Exposure Duration & 
LOEC (ng/L) 
Life stage Reference 
Rainbow trout (Oncorhynchus mykiss) 6 months; 1 parr to F1 Hansen et al., 1998 29 
 21 days; 10 males Routledge et al., 1998 76 
 14 days; 19-26 juvenile Thorpe et al., 2003 77 
    
Atlantic salmon (Salmo salar ) 26 days; 8 parr Bangsgaard et al., 2006 78 
    
Medaka (Oryzias latipes) 2 generations; 2.9 P.H. to F1 Seki et al., 2005 35 
 21 days; 8.9 males Seki et al., 2006 79 
    
Fathead minnow (Pimephales promelas) 21 days; 28.6 males Seki et al., 2006 79 
    
Zebrafish (Danio reio) 21 days; 85.9 males Seki et al., 2006 79 
    
Eelpout (Zoarces viviparus) 10 days; 50000 males Korsgaard, 2006 80 
    
Java-medaka (Oryzias javanicus) 6 months; 68 Males P.H. Imai et al., 2005 69 
• P.H., post-hatch. 
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does not provide conclusive evidence that 
this is so, i.e. further research is required 
before Victoria can be assured that 
hormones in recycled and recyclable water 
are not a threat to Victorian aquatic 
environments. 
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5. Conclusions 
 
The project has addressed such questions 
of broad interest to the community and 
WWTP managers as: 
• What is the likelihood that my WWTP 
effluent is estrogenic? 
• Was testing undertaken at the right 
time (season)? How does this influence 
the data obtained and the wildlife risk? 
• How accurate and precise were the 
tests?  
• Will fish and other organisms be 
affected by the discharge? How much 
exposure is required before an effect is 
observed and is it reversible?  
The willingness of consumers to use 
reclaimed water from municipal 
wastewater treatment plants is dependent 
on their confidence that the reclaimed 
water is safe to use and that the intended 
applications will be managed to promote 
sustainable environmental outcomes. 
Consumer confidence and trust is fragile 
and likely to only be built over time. So, 
what were the drivers for choosing particular 
chemicals? The occurrence of endocrine 
disrupting chemicals (EDCs) in the aquatic 
environment and their impact on 
indigenous fauna has generated a 
significant amount of scientific and public 
interest since the publication of the book 
Our Stolen Future. Since then, substantial 
evidence has emerged that many 
chemicals induce hormone-like effects in 
wildlife and humans, at the concentrations 
observed in the environment, i.e. at 
concentrations much lower than those 
used in toxicity tests designed to see if the 
chemicals cause cancer. Chemicals with 
hormonal activity, i.e. potential endocrine 
disrupters, include: 
• Natural hormones. These can be from 
any animal, and once released into the 
environment, chemicals produced by 
one species can exert hormonal actions 
on other animals, e.g. human hormones 
unintentionally reactivated during the 
processing of human waste in sewage 
effluent, may result in changes to fish.  
• Natural chemicals, including toxins 
produced by components of plants 
(phytoestrogens, such as genistein or 
coumestrol) and certain fungi.  
• Synthetically produced 
pharmaceuticals that are intended to be 
highly hormonally active, e.g. 
components of the contraceptive pill 
and treatments for hormone-responsive 
cancers.  
• Man-made chemicals and by-products 
released into the environment.  
• The effluent from municipal 
wastewater treatment plants (WWTPs) 
is considered the source of much of the 
EDC input into aquatic environments, 
and the naturally-occurring, human sex 
hormones the source of much of the 
hormonal activity in most WWTP 
effluents.  
• Hence, the choice to focus on the 
steroid hormones in this project. 
 
What is the likelihood that my WWTP effluent 
is estrogenic? In short, the likelihood is 
high, but it also apparent that for the most 
part levels in Victorian WWTPs are likely 
to be low (generally less than 10 ng/L 
EEQ).  
 
Was testing undertaken at the right time 
(season)? Clearly, the more monitoring that 
is undertaken, the easier it will be to 
answer this question. That said, in this 
study testing was undertaken twice, in 
Winter and Summer, to assess if there 
were seasonal effects on water quality. 
• The data produced by the Winter 
testing regime provides information on 
the hormonal activity of stored waters 
(generally lagoon systems, and lagoons 
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associated with many AS plants, 
particularly in the north of the state). 
The data produced can, therefore, be 
used when assessing the risk of using 
this stored water in the Spring, e.g. as 
replacement environmental flow or 
application to land. 
• The data produced by the Summer 
testing provides information on the 
hormonal activity of waters during 
peak re-use, and can be used when 
assessing the risk of recycling this 
water to land, or into amenity waters 
(e.g. ponds, urban lakes). 
 
How accurate and precise are the results? This 
question can also be put another way, how 
credible are the results? Although implicitly 
this question questions the credibility of 
the project team, it is not an unfair 
question, given the importance of the 
issue.  
• In part the credibility of the results lies 
in the extensive, international research 
experience of the lead investigators, 
particularly the almost two decades of 
experience measuring persistent 
organic pollutants (e.g. dioxins, dioxin-
like chemicals, DDT etc.) using 
complex sample preparation and 
measurement techniques.  
• In part, credibility lies within the 
quality-systems approach taken by 
Environmental Health & Chemistry’s 
laboratories. The methods used in this 
project were non-standard (there are as 
yet no recognised standard methods to 
do what we were asked to do), and so 
quality assurance testing was 
undertaken routinely during the testing 
program.  
• In part, the credibility of our results lies 
in the long-term collaboration with the 
National Institute for Environmental 
Studies (NIES) in Japan, which was 
used to access some of the tools used in 
this investigation, i.e. validation of data 
by experts in the technique in an 
international (and internationally 
recognised) research organisation. 
• In part, credibility of technique is 
provided because other research 
groups in Australia and New Zealand 
have also been basing their EDC 
research on collaboration with the same 
group at NIES.  
• In part, the credibility of our results lies 
in validation of data trends through a 
second technique based on different 
analytical technology i.e. chemical 
measurement of estrogens and 
androgens using enzyme-linked 
immunosorbent assay (ELISA) 
technology.  
That said, we recognise that there are 
some interesting differences between our 
results and those found in southern 
Queensland, and that these may be the 
result of methodological differences. We 
recognise that, in part, in future, the 
credibility of our results (and those of 
other laboratories) will rest in active, 
successful participation in inter-laboratory 
validation trials.  
• One conclusion and recommendation 
from these studies is that national, 
inter-laboratory validation trials are 
required. Such trials are, perhaps, best 
organised by N.A.T.A., funded through 
the CRC for Water Quality and 
Treatment, and stimulated by the water 
authorities themselves. 
 
What is the likely environmental impact of 
current / future discharge of WWTP effluents 
into receiving waters? This is a difficult 
question to address. Although our results 
suggest that the estrogenic activity of 
Victorian treatment plants is higher than 
that observed elsewhere in Australia 
(although in and of itself this observation 
may simply reflect the lack of monitoring 
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undertaken in other states and the 
difficulties associated with comparing 
like-for-like WWTPs), they also highlight 
that the level of hormonal activity, and the 
concentrations of individual hormones are 
relatively low.  
• All Victorian WWTP effluents studied 
were hormonally active to some extent, 
containing both estrogens and 
androgens. 
Typically, in environmental risk 
assessment one first looks to agreed 
national or international guideline or 
trigger values for the type of waters being 
assessed. In this case, there are as yet no 
guideline values, although the UK 
Environment Agency is apparently 
considering a trigger value of 1 ng/L EEQ 
in river water (Pers. Comm., Sue Jobling, 
Brunel University, London). Without 
guideline values to drive the assessment, 
then one compares a chemical’s 
concentration in a sample (in this case a 
WWTP effluent) with data obtained from 
toxicological experiments in which the 
concentration known to elicit a specific 
effect has been determined. In this case, 
levels of estradiol were typically between 
the lowest reported level to induce the 
production of female-only proteins in 
male fish (plasma vitellogen; 1 ng/L), and 
the  lowest concentration of known to 
induce intersex in fish (8 ng/L), and 
consequently there may be some site 
specific risks, i.e. to a sensitive aquatic 
receiving environment. 
One assumption commonly made when 
assessing chemicals in WWTP effluents is 
that the WWTP discharges will be diluted 
significantly in the receiving environment. 
Ten-fold (10x) dilution of most of the 
effluents studied would bring their 
estradiol concentrations below the lowest 
reported level to induce plasma 
vitellogenesis in male fish, and in such 
cases there may be minimal risk of 
endocrine disruption caused by the 
steroid hormones. 
• To assume significant dilution may not 
be appropriate in some circumstances, 
e.g. where the discharge represents all, 
or most of, the environmental flow in a 
waterway, or where discharges are to 
enclosed water bodies (e.g. lakes).  In 
such cases, there may be significant 
risks to aquatic wildlife. 
In this study, we did not measure the 
concentration of one of the most potent 
steroidal hormones, namely ethinyl 
estradiol (EE2). This synthetic compound 
is the active ingredient in many forms of 
contraceptive pill, and has a potency at 
least 25 times that of estradiol, and is 
known to cause physiological impacts at 
concentrations as low as 0.1 ng/L.  
Consequently if only relatively small 
proportion of the observed estrogenicity is 
due to EE2, the risk of impacts in receiving 
environments may be greater than might 
otherwise be anticipated.  
• No account is taken of additive or 
synergistic effects of mixtures of 
chemicals, i.e. the chemical cocktail 
found in the effluent may induce effects 
equal to the sum or, or greater than the 
effects seen by individual chemicals in 
the mixture at equivalent 
concentrations. 
No instrument can measure toxicity or 
other chemical impacts on organisms. 
Moreover, the in vitro assays used in this 
study are useful as screening tools for 
monitoring studies, but they are a 
simplification of the in vivo situation, i.e. 
although they are living systems in vitro 
tests do not have the complexity (in scale 
or scope) of more complex organisms, and 
thus do not take into account processes 
such as bioavailability, metabolism and 
excretion, or cross-talk between biological 
pathways, nor address effects that result 
from multiple mechanisms. Consequently, 
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to truly assess the risk (hormonal impact) 
of these WWTP effluents, in vivo testing 
needs to be undertaken, ideally with a 
representative native species but failing 
that with a ‘standard’ species such as the 
fathead minnow. 
The project has provided a large amount 
of baseline data for Australian researchers 
and, although undertaken with reasonably 
limited scope, has identified a number of 
areas that require further investigation. 
Based on the data collected in this study, 
the following areas are worthy of 
consideration of funding by SmartWater 
and/or the Victorian Water Trust. 
• A study of the hormonal activity of 
mechanical plants using trickle filter 
technology (these were not investigated 
in this study, and are known to have 
limited removal efficiency for steroid 
hormones). 
• A study of the seasonal variation in 
hormonal activity at selected WWTPs, 
e.g. those discharging to freshwater 
environments, supplying major 
recycling schemes, or serving major 
tourist destinations. 
• A study exploring the seasonal changes 
in phytotoxicity of WWTP effluents, 
and the potential impact on agricultural 
crops.  
• A study of Victoria’s riverine 
environments to ascertain whether 
there have already been impacts on fish 
(native and for some exotics (e.g. trout, 
redfin perch)) in those Victorian 
waterways currently regularly 
receiving WWTP discharges (a major 
knowledge gap identified by this 
study).  
• A study exploring other sources of 
EDCs in the environment, e.g. from 
agriculture, forestry, the urban 
environment. 
• A study evaluating fish development 
when grown in 100% WWTP effluent 
compared and contrasted to fish 
developing in natural waters. Although 
exploring a ‘worst-case exposure 
scenario,’ WWTPs have been identified 
as a reasonably secure water source for 
aquaculture development in northern 
Victoria, which in turn could pose an 
ecological risk if native fish are grown 
for restocking purposes (through 
stocking of developmentally impacted 
fish). DPI has a project plan ready that 
would cover this knowledge gap ‘on 
the drawing board,’ and which would 
be undertaken by a coalition involving 
DPI, water authorities and university 
academics. 
• Development of an in vivo test system 
using a representative native fish.  
• A study further exploring androgen 
concentrations in effluent and 
measurement of impact (cause-effect) 
using an in vivo system.  
• A study exploring the behaviour of 
steroidal hormones in sediments 
(especially anoxic sediments) in aquatic 
systems receiving WWTP effluents (to 
assess the potential for a ‘reservoir 
effect’). 
• A study of the environmental fate of 
steroid hormones in field soils, in situ 
in the presence of co-contaminants (to 
assess risks to soil health and the 
potential transport risks from enhanced 
mobility associated with recycled 
water). 
Ultimately, the study has again 
highlighted that it is not just the big city 
that produces hormonally active effluent 
(as one might intuitively believe), but also 
smaller communities. Indeed, some of the 
effluent from WWTPs serving small 
communities is more hormonally active 
than that of the larger cities.  
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• The best advice for treatment plant 
operators is, “have the hormonal 
activity of your plant measured.” 
When this program began, the ‘watching 
brief,’ being held in Australia on the topic 
of endocrine disrupting chemicals and 
their potential effects on aquatic wildlife 
was considered too passive by many. It 
still is, by some. Despite the assurance our 
results may provide, there is still a need 
for further extensive on-ground, 
reassurance research to provide data for 
higher-level risk assessment by industry 
and government agencies.  
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